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ABSTRACT 
This study investigated the effects of participation and self-efficacy on six-month outcome 
from inpatient Minnesota model chemical dependence treatment. The goal was to 
determine the extent to which effects on outcome that could be attributed to participation 
in treatment were mediated by self-efficacy. Covariance structure analyses showed that 
self-efficacy predicted relapse latency at the six-month follow-up, converging with similar 
findings from smoking cessation research. A supplementary model including both general 
participation and a more specific topic group dose measure showed that these factors 
produced significant but competing effects on self-efficacy, with opposing indirect effects 
on relapse latency that were completely mediated by self-efficacy. These results support 
the use of self-efficacy as a common metric for examining treatment effects. 
lX 
CHAPTER 1 
INTRODUCTION 
Alcoholism treatment programs based on Minnesota model chemical dependence 
(MMCD) principles, still the dominant treatment modality in the United States today at 
the practice level (Kahle & White, 1991 ), postulate that alcoholism is a disease whose only 
legitimate treatment goal is abstinence (IOM, 1990). For this reason, MMCD treatment 
places its primary emphasis on instilling beliefs and skills that will facilitate and maintain 
abstinence. The goal ofMMCD treatment can be seen as an attempt to inculcate both 
positive and negative outcome expectations regarding alcohol use: life-long abstinence 
from alcohol is stressed as the only "cure," and attention is directed to the belief that a 
return to drinking at any level will precipitate full-blown relapse. At the same time, both 
positive and negative efficacy expectations are also instilled: the individual must be 
convinced that mastery over drinking impulses can be attained, yet he or she must 
additionally accept the fact of powerlessness and inability to cope when faced with alcohol 
(Rollnick & Heather, 1982). In MMCD programs, these changes in expectations are 
accomplished by breaking down "denial," by providing a new normative reference group 
consisting of other recovering individuals, and by precipitating a "conversion experience" 
to a new belief system in which abstinence is paramount (Cook, l 988a). 
Apart from a general lack of controlled studies of MMCD outcome (Cook, l 988b; 
Miller & Hester, 1986), three key problems plague MMCD research. The first of these is 
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the difficulty of operationalizing core constructs such as surrender of personal control to a 
"higher power," denial, or the conversion experience believed to be central to treatment 
success (Cook, 1988a; Marlatt, 1985; Miller, 1985; Miller & Rollnick, 1991; 
Morgenstern, Frey, McCrady, Labouvie, & Neighbors, 1996; Morgenstern & Mccrady, 
1992; Room, 1993). This situation has lead to attempts to frame MMCD processes in the 
language of expectations (cf., Rollnick & Heather, 1982, above), but this carries problems 
of its own. The expectancy construct has a venerable tradition in psychological research 
(Bandura, 1986; Bolles, 1975; Fishbein & Ajzen, 1975; MacCorquodale & Meehl, 1954; 
Maier & Seligman, 1976; Osgood, 1950; Rotter, 1954; 1966; Tolman, 1932), and has 
been widely used in studies of the etiology, maintenance and treatment of addiction 
(Stacy, Widaman & Marlatt, 1990). As a result, controversies in this area abound, ranging 
from the question of alcohol versus abstinence expectations, to debates about additive 
versus multiplicative combinations in expectancy-value models, or the factor structure of 
expectancy scales versus cluster models and spreading activation (Brown, 1985; Goldman, 
1994; Leigh, 1989; Solomon & Annis, 1989; Young & Oei, 1993). Consequently, there 
appears to be no widely accepted set of expectancy measures upon which to base a 
comprehensive analysis of MMCD treatment processes. 
This is compounded by a second problem, the question of motivation. The current 
view in addictions research seems to be that the utility of the confrontational approach 
employed in MMCD programs is mediated by patient motivation and compliance with 
treatment recommendations (Brownell, Marlatt, Lichtenstein & Wilson, 1986; IOM, 
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1990). In fact, motivation is widely believed by those from varying theoretical perspectives 
to be a key factor in recovery from alcohol-related problems, constituting one of the few 
consistent predictors of alcoholism treatment outcome (Fawcett, Clark, & Aagesen, 1987; 
Finney, Moos, & Chan, 1981; Fuller, Branchey, & Brightwell, 1986; Westermeyer & 
Neider, 1984). As Miller's (1985) cogent review of the subject points out, however, 
motivation has also been operationalized in various ways, including agreement with 
therapist, acquiescence to the sick role, expressed desire for help, subjective distress, 
compliant attitude, and apparent willingness to trust the therapist's judgment. An 
individual's stated willingness or intention to participate in treatment has been found to be 
unrelated to actual participation or outcome, and while therapist perceptions have been 
related to compliance with treatment and outcome, this could well be due to the self-
fulfilling nature of therapist expectancies. Miller also notes that the typical trait-based 
approach to motivation tends to discourage intervention because it attributes motivation 
to stable internal sources. 
A third problem surrounding MMCD research is closely related to the two 
previous issues. This is the use of"black box" evaluation designs, focusing primarily on 
the treatment program taken as a whole, or upon differences in comparison with other 
treatment modalities, rather than upon treatment processes and components (Moos, 
Finney, & Cronkite, 1990; Morgenstern & McCrady, 1992). By taking steps like assessing 
the motivational level and degree of participation of patients, process factors like these 
could be controlled in the examination of post-treatment drinking behavior and we could 
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determine whether or not this level of specificity enhances the prediction of outcome 
(Chen & Rossi, 1983). Yet attempts to incorporate process in MMCD evaluations are 
most often limited to specification of program setting or length of stay, and it is typically 
assumed that all patients within a program receive the same treatment. Research shows 
that this is not the case. Treatment experiences differ according to opportunities for choice 
(Kissen, Platz & Su, 1971 ), level of alcohol dependence and pattern of use (Simpson & 
Sells, 1983), pre-treatment history (Billings & Moos, 1984), and pre-existing expectations 
(Davies, 1981). Patients in the same programs, in varying degrees of withdrawal and 
recovery, selectively attend to different services (Becker & Jaffe, 1984), function at 
different levels early and late in treatment (Cernovsky, 1984), and get different amounts of 
staff attention and program resources (Berman, Meyer & Coates, 1984). As a result, we 
cannot identify the strength or integrity of treatment provided to the individual patient, 
much less the reasons for, or the effects of, this type of self-selectivity or differential 
component delivery (Moos, Finney & Cronkite, 1990). Process analysis is of particular 
importance in evaluating MMCD programs, since the long-term goal of abstinence, usually 
measured as the primary outcome criterion in evaluation studies, depends on the short-
term goal of inculcating beliefs and converting the patient. Since this intermediate process 
of conversion is so hard to operationalize and is so closely related to the sticky question of 
motivation, it has been neglected in the design ofMMCD research. As a result, a critical 
gap exists in this literature. 
Calls to focus on these issues have led to significant progress in addressing 
methodological problems (Longabaugh, 1989), and recent attempts to identify the key 
components of various schools of treatment are also encouraging (e.g., McLellan, 
Alterman, Cacciola, Metzger & O'Brien, 1992; Moos, Finney & Cronkite, 1990; 
Morgenstern & McCrady, 1992). The problem with applying that strategy in this case is 
that MMCD treatment is intended as a multi-component approach, designed to 
incorporate promising elements drawn from various sources (IOM, 1990). Survey 
research confirms that this is the case among practitioners who espouse disease model 
tenets (McCrady, 1994), and it suggests that the MMCD model is "becoming a more 
complex treatment approach integrating the therapeutic aspects of other models" 
(Morgenstern & McCrady, 1992). This eclecticism has received post-hoc justification in 
light of recent evidence that common stages of change can be identified across addictive 
behaviors, and that different processes are utilized to best advantage by those at different 
stages (Prochaska & DiClemente, 1983). Those in contemplation or precontemplation 
stages, for example, may get the most benefit from a motivational intervention, which aids 
them in moving to the next stage, whereas those who have already progressed to the 
action or maintenance phase may be the ones who profit most from behavioral techniques 
and skills training (Prochaska, DiClemente & Norcross, 1992). 
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One promising avenue for MMCD research might be to view this type of treatment 
as an amalgam of motivational interventions (e.g., persuasion and modeling) and skills 
training (performance) in the context of self-efficacy enhancement. Bandura introduced 
self-efficacy 
... based on the principal assumption that psychological procedures, 
whatever their form, serve as a means of creating and strengthening 
expectations of personal efficacy .... By postulating a common mechanism 
of operation, this analysis provides a conceptual framework within which 
to study behavioral changes achieved by different modes of treatment 
(Bandura, 1977, pp. 193 & 195) 
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As described by Bandura (1977; 1986), self-efficacy is considered a central 
cognitive mediator of behavior, influencing behavioral choice, and determining the amount 
of effort expended in performance, and persistence in the face of difficulties. Since its 
introduction self-efficacy has been successfully applied in domains as diverse as sports 
performance (Feltz, 1982 }, vocational choice (Betz & Hackett, 1981 }, academic 
performance (Bandura & Schunk, 1981 }, social skills training (Lee, 1984), and treatment 
of phobias (Williams & Watson, 1985). In the past two decades, self-efficacy has become 
one of the most frequently cited terms in the social, clinical and counseling psychology 
literature (Maddux & Stanley, 1986). 
Bandura (1977) identified four sources of self-efficacy information: performance 
accomplishments, vicarious experience (live or symbolic modeling}, verbal persuasion 
(including interpretation and self-instruction}, and visceral experience (e.g., emotional 
arousal). Performance is thought to be the strongest source of efficacy expectations 
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because it based on direct evidence of personal mastery, but each of the other sources, 
albeit weaker, is still a potentially significant contributing factor. Since MMCD treatment 
incorporates all four sources of efficacy information in its multi-modal package, MMCD 
treatment effects and key constructs like the intermediate goal of conversion could 
presumably be assessed in terms of changes in alcohol abstinence self-efficacy. This would 
do precisely what Bandura intended, putting behavioral treatments for alcohol problems 
and MMCD treatment in the same metric for study and comparison. 
In fact self-efficacy has been widely used as a mediating concept in etiological 
theories of addictive behavior, and it has a demonstrated track record of success as a 
predictor of smoking cessation treatment outcome (Baer, Holt & Lichtenstein, 1986; 
Condiotte & Lichtenstein, 1981; Di Clemente, 1981; DiClemente, Prochaska & Gilbertini, 
1985; Velicer, DiClemente, Prochaska & Brandenburg, 1985). Unfortunately, only a few 
studies could be located in which self-efficacy has been examined in relation to alcoholism 
treatment (e.g., Annis & Davis, 1988; Burling, Reilly, Moltzen & Ziff, 1989; Di Clemente, 
Carbonari, Montgomery & Hughes, 1994; Solomon & Annis, 1990), and in none of these 
cases was the focus of research MMCD treatment. 
To remedy this, and to address some of the issues outlined above, the present 
study used self-efficacy in conjunction with self-reported levels of treatment participation 
to examine the extent to which effects on outcome that could be attributed to participation 
in MMCD treatment were mediated by self-efficacy at discharge. 
CHAPTER2 
COMPETING THEORETICAL PARADIGMS 
This investigation involves an analysis ofMMCD treatment - which is based on a 
disease model of alcoholism - from the perspective of self-efficacy - a social learning 
theory principle. The disease model and the social learning approaches have been seen by 
some as competing theoretical paradigms (cf, McCrady, 1994; Morgenstern & McCrady, 
1992). For this reason, a brief overview of the two perspectives will be presented. 
The Disease Model 
The emphasis in the disease model is on biological parameters, with a focus on the 
pharmacological effects of alcohol. It is believed that for some individuals a (presumably 
genetic) predisposition affects alcohol metabolism, such that consumption of alcohol 
inevitably leads to increased craving and loss-of-control drinking. This is seen as a lifelong 
condition, with no possibility of cure: the only solution is to maintain complete and total 
abstinence. This disease is assumed to be latent in the affected individual before the first 
drink is ever taken, to manifest itself in biological, psychological and social sequellae, and 
to remain in existence after drinking stops, regardless of the duration of abstinence. The 
disease model is usually extended to include the concept of"chemical dependence," the 
belief that addiction-prone individuals are vulnerable to other mood-altering substances as 
well as alcohol, but the core concept is loss of control. The disease model considers 
alcoholism to be "chronic, primary, and progressive," meaning that alcohol is the focus of 
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intervention, rather than merely a symptom of underlying problems, and that if left 
unchecked, the disease will follow a deteriorating course. From the point of view of this 
model, any consumption of alcohol after a period of sobriety indicates relapse (Jellinek, 
1952; Laundergan, 1982; McCrady, 1994). 
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Since the cause of the disorder is irremediable, the main focus in treatment 
programs based on this model (e.g., MMCD treatment) is promulgating this perspective 
and "converting" the affected individual to the disease model point of view. Cook (I 988a) 
lists four key elements of treatment: (a) attention to the possibility of change, (b) emphasis 
on the disease concept, ( c) a goal of abstinence and improved lifestyle, and 
( d) participation in a twelve-step program such as Alcoholics Anonymous (AA). These 
elements encompass growth of a broader awareness, recognition and acceptance of choice 
and responsibility, and reconstruction of relationships. In this context, the treatment 
program provides opportunities to focus on change, an atmosphere conducive to and 
supportive of change, and peer-group counseling, information, and professional guidance. 
A Model Based on Social Leaming Principles 
In recent years, the field has seen the emergence of a new model of the etiology 
and treatment of alcoholism based on cognitive psychology, social learning theory, and 
experimental social psychology (Marlatt, 1985). This approach uses an analysis of the 
expectations, attributions, and intentions believed to constitute the addictive behavior 
cycle to integrate information about relapse processes across substances. 
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In this analysis, when faced with a difficult or challenging situation, the individual 
must initiate a coping response. Due to the accumulation of positive outcome expectancies 
for alcohol - which result from observational learning, as well as direct experience - the 
coping mechanism selected in response to stress is most likely to be alcohol consumption. 
Use of alcohol as a coping response is reinforced by its immediately gratifying effects 
(e.g., drinking calms anxiety), which further strengthens positive outcome expectations for 
drinking. Over time, initiation of drinking as a coping mechanism becomes a habit, an 
automatic response to stressful situations. Given this scenario, attempts to change the 
addictive behavior focus on bringing the habit back to the level of conscious awareness by 
identifying "high risk" situations (i.e., the stressful circumstances most likely to trigger 
alcohol use), and developing risk avoidance strategies and alternative coping mechanisms 
designed to replace alcohol consumption (Marlatt, 1985). 
Fallowing Bandura' s ( 1977) analysis of self-efficacy, Marlatt ( 1985) outlines the 
events that comprise relapse to alcohol use after a period of abstinence. If the individual 
initiates an alternative coping response when faced with a high-risk situation, this increases 
self-efficacy to abstain from drinking, weakens positive outcome expectations for alcohol, 
and decreases the probability of relapse. However, if no alternative coping response is 
initiated, or if the coping response is inadequate or unsuccessful, abstinence self-efficacy 
decreases and the salience of positive outcome expectations for alcohol increases. This is 
likely to eventuate in a "lapse" or "slip," a retreat into an episode of drinking to cope. To 
emphasize the parallel roles of self-efficacy and positive outcome expectancies in this 
model, the events constituting the relapse process are depicted schematically in Figure 1. 
High Risk 
Situation 
Figure 1 
Schematic Depiction of the Relapse Process 
....---------+----------. 
Alternate 
Coping Response 
Alcohol 
Consumption 
Abstinence 
Self-Efficacy 
Positive Outcome 
Expectancies for Alcohol 
'---------+----------' 
Note. Adapted from "A cognitive-behavioral model of the relapse process," by G. A. 
Marlatt, 1985, in Relapse prevention: Maintenance strategies in the treatment of 
addictive behaviors (p. 38), G. A. Marlatt, & J. R. Gordon, Eds., 1985. NY: Guilford 
Press. Copyright 1985 by Guilford Press. 
Given that a lapse has occurred, a second phase begins that Marlatt (I 985) calls 
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the abstinence violation effect. Here, attributions about the cause of the lapse are made. If 
attributed to internal factors, a negative reaction ensues from comparing immediate 
behavior (lapse) with ideal behavior (abstinence). The larger the discrepancy (dissonance), 
the greater are reactions of guilt and self-blame, and the greater the likelihood of either 
behavioral reactance (retreating to the addictive behavior) or cognitive reactance 
(redefining the self-image in line with the lapse). Either way, the probability ofrelapse 
increases as a result of internal attributions about the cause of the lapse. As Rollnick and 
Heather (1982) point out, abstinence-oriented treatment stressing the uncontrollable 
nature of drinking (i.e., negative alcohol abstinence self-efficacy, or the loss-of-control 
tenet) may exacerbate this problem, setting the stage for a self-fulfilling prophecy. 
Contrasts and Comparisons 
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One of the main benefits of the disease model is that it removes stigma by 
absolving the alcoholic from guilt or responsibility for the condition, which allows the 
person to seek help (Marlatt, 1985). The key facets of treatment are believed to have their 
effect by enabling the individual to "place trust outside the realm of conscious effort" and 
focus on the easier step of resisting temptation (Cook, l 988a). Self-help and mutual-aid 
elements like AA attendance and social reintegration within a community of recovering 
individuals serve to convert the alcoholic's social network from blame to support, which 
helps increase responsibility and participation. These elements comprise a well-developed 
ideology and provide a fixed community of belief, an action program, constructive activity 
toward shared goals, rewards for sobriety, and the living example of individuals who have 
remained sober as evidence that recovery is possible. 
A central concept in social learning-based treatment, on the other hand, is the view 
that beliefs about the course of events play a significant role in determining the actual 
course of events. If any lapse is equivalent to failure, as taught in the disease model, the 
individual is considered more likely to relinquish efforts to control drinking behavior after 
a lapse has occurred and yield to what is perceived as "inevitable." By contrast, if a lapse 
is framed as a chance for new learning to occur, the individual is believed to be less likely 
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to abandon efforts to control behavior. 
As noted by McCrady {1994), contrasts between the two paradigms are apparent. 
The language is different - the disease model focuses on a presumed disease entity, 
whereas the social learning approach addresses alcoholism as a learned habit. The disease 
model is based on a univariate view of the etiology of alcoholism, while in the behavioral 
model the emphasis is on a variety of internal, environmental, and interpersonal 
determinants of alcohol-related problems. Disease model proponents see exaggerated 
beliefs about personal control as part of the problem, as compared to the social learning 
approach, which tries to enhance mastery and personal control. Abstinence is considered 
the only appropriate treatment goal from the disease model perspective, whereas the social 
learning viewpoint focuses on a negotiated, rational choice of goals in which controlled 
drinking may be considered appropriate for some individuals. 
As McCrady ( 1994) points out, given these different bases (e.g., mastery and self-
control versus powerlessness and surrender), an integration at the level of theory seems 
unlikely, but several commonalities suggest that the two paradigms can be integrated at 
the level of practice. Both models place a strong emphasis on initial behavior change. Both 
prescribe courses of action, emphasizing alternate behaviors and activities incompatible 
with drinking. Both focus on identifying risk situations, and encourage recognition and 
modification of dysfunctional cognitions. Both stress the role of negative affect in creating 
high risk situations, and both emphasize the benefits of social networks that reinforce 
abstinence. Given different theoretical bases but many common elements and processes, a 
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strategy of matching patients to treatments - coordinating treatment philosophy with the 
personal characteristics of individuals - may lead to better outcomes overall. 
The social psychological relapse prevention approach outlined by Marlatt (1985) 
and Annis (1986) achieves an admirable and easily-understood integration of self-efficacy 
and outcome expectancy constructs, and has received a great deal of empirical support, in 
terms ofboth its individual components (Baer, Holt, & Lichtenstein, 1986; Condiotte & 
Lichtenstein, 1981; Curry, Marlatt, & Gordon, 1987; Di Clemente, 1986; Harackiewicz, 
Sansone, Blair, Epstein, & Manderlink, 1987; Mann, Chassin, & Sher, 1987), and in terms 
of the program as a whole (Annis, 1986; Cooper, Russell, & George, 1988; Velicer, 
DiClemente, Rossi, & Prochaska, 1990). In contrast, outcome evaluations of treatment 
programs based on the disease model have yielded equivocal results and been criticized for 
methodological shortcomings by a number of authors (e.g., Cook, 1988b; Emrick & 
Hansen, 1983; Holder, Longabaugh, Miller, & Rubonis, 1991; Miller & Hester, 1986; 
Moos, Finney, & Cronkite, 1990). However, MMCD treatment is intended as a multi-
component approach designed to incorporate promising elements drawn from various 
sources (IOM, 1990), and this includes elements of social learning theory. Recent survey 
research confirms that such principles are being employed by practitioners who espouse 
disease model tenets (McCrady, 1994; Morgenstern & McCrady, 1992), suggesting that 
the two models are neither mutually exclusive nor necessarily incompatible. This supports 
the use of social learning concepts like self-efficacy as a means of evaluating MMCD 
treatment. 
CHAPTER3 
EMPIRICAL INVESTIGATIONS 
Self-efficacy has often been studied in smoking cessation programs, but much less 
frequently in the context of treatment for alcoholism and eating disorders (Di Clemente, 
1986~ Stephens, Wertz, & Roffman, 1995). In fact, only a small number of studies using 
self-efficacy in the context of alcoholism treatment outcome could be found. These studies 
and several of the smoking investigations will be described here. 
Self-Efficacy and Smoking Cessation 
In one of the earliest reports applying the self-efficacy construct to smoking, 
Di Clemente ( 1981) compared three different smoking cessation procedures, measuring 
self-efficacy in 63 individuals one month after quitting and abstinence five months later. 
None of the demographic or smoking history variables predicted abstinence at follow-up, 
but self-efficacy did. There were significant correlations between self-efficacy and both 
weeks of successful abstinence and self-reports of difficulty in maintaining abstinence. 
Since all subjects were abstinent at the time of the self-efficacy assessment, outcome 
differences were not attributable to differences in the ability to achieve abstinence. 
DiClemente concluded that efficacy appeared to be highly positively related to the ability 
to maintain smoking abstinence, even though the range of the efficacy measure appeared 
to be restricted. Further, he suggested that his results supported the view that self-efficacy 
was superior to past behavior as a predictor of subsequent abstinence rates. 
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Condiotte and Lichtenstein ( 1981) conducted one of the most widely-cited self-
efficacy studies in the addiction field. They collected self-efficacy ratings from 78 
participants in two smoking cessation programs both before treatment and at the end of 
treatment, along with follow-ups at five weeks, eight weeks and 12 weeks after 
termination. Some subjects were also asked to monitor smoking behavior, mood states, 
and self-efficacy on a daily basis during the first five weeks after treatment. These 
investigators found that treatment significantly enhanced self-efficacy in both programs 
and that self-efficacy continued to increase during the follow-up period. Using multiple 
regression to predict abstinence status and time to first use, they were able to account for 
32% of the variance in smoking status at the initial follow-up, and 48% of the variance in 
time to first use. Further, they found a high degree of correspondence between the lowest 
self-efficacy scores and the circumstances surrounding the first relapse to smoking. On the 
basis of these results, Condiotte and Lichtenstein concluded that there was indeed a strong 
inverse relationship between abstinence self-efficacy and smoking behavior at follow-up. 
A large-scale study of957 smokers conducted by DiClemente et al. (1985) showed 
that, as expected, smokers in earlier stages of change (i.e., contemplation or pre-
contemplation stages) had lower levels of smoking abstinence self-efficacy, while those 
who had already quit (i.e., those in the later action or maintenance stages of change) 
showed higher levels of abstinence self-efficacy. Similar to the results reported by 
Di Clemente ( 1981 ), efficacy was found to be superior to past performance as a predictor 
of smoking behavior in this study. The investigators concluded that self-efficacy reliably 
discriminated between smoking status categories, and that it was significantly correlated 
with specific activities related to cessation and maintenance. 
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Velicer, DiClemente, Prochaska, and Brandenburg (1985) conducted a smoking 
cessation study using 116 subjects which demonstrated that scores on their pros of 
smoking scale (which measured positive outcome expectancies for smoking) were high for 
those in pre-contemplation, contemplation, and relapse stages of smoking change, but low 
for those in the action and maintenance stages. Slightly different results were found for the 
cons of smoking (negative outcome expectancies): those in pre-contemplation and 
maintenance phases showed low con scores, whereas cons were highest for those in the 
contemplation and action stages, a finding attributed to the lower salience of smoking cues 
in general for those in the maintenance phase. More relevant here, self-efficacy was found 
to be one of the best predictors of smoking outcome at six-month follow-up. 
Baer, Holt, and Lichtenstein ( 1986) conducted a somewhat more methodologically 
rigorous investigation of self-efficacy with 146 participants in several smoking cessation 
programs. They attempted to address several questions about self-efficacy measurement, 
as well as to examine competing models of self-efficacy effects. They found that the self-
efficacy measure they used was primarily unidimensional in nature, that there were low to 
moderate positive correlations with past behavior, and that self-efficacy was unrelated to 
pre-treatment motivation but significantly positively related to pre-treatment levels of 
social support. In terms of outcome, their results showed significant positive correlations 
between self-efficacy and abstinence status, and negative correlations between self-efficacy 
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and rate of smoking at the one-, two-, three- and six-month follow-ups, although these 
results were not significant when the sample was restricted to those who had attained 
abstinence by the end of treatment. They also demonstrated that self-efficacy at earlier 
follow-up points was highly correlated with self-efficacy at later points. Baer et al. 
concluded that self-efficacy has incremental predictive validity for smoking rate but not for 
smoking status, and that a model in which both self-efficacy and smoking status made 
independent contributions to subsequent smoking status was supported best by their data. 
Self-Efficacy and Alcohol Treatment 
Burling, Reilly, Moltzen, and Ziff (1989), citing a lack of self-efficacy research in 
relation to treatment for drug- and alcohol-related problems, set out to examine a series of 
questions with a group of 419 alcohol and other drug abusers in a therapeutic community 
treatment setting. Using a modified version of Annis's (1986) Situational Confidence 
Questionnaire (SCQ), they wanted to determine: (a) ifthere were baseline differences in 
self-efficacy between alcoholics and drug users, (b) if self-efficacy increased during 
treatment, ( c) if those with high self-efficacy at discharge were less likely to relapse, ( d) if 
there were self-efficacy differences between abstinent versus relapsed groups at any of 
several monthly follow-up points, and ( e) if those who eventually relapsed had correctly 
identified the circumstances surrounding the relapse in ratings made during treatment. 
Although 419 subjects were admitted to the study, only 56 could be followed after 
discharge. Results showed that: (a) there were no differences between alcohol and other 
drug users at baseline, (b) there were significant increases in SCQ scores from baseline to 
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discharge, ( c) abstinent and relapse groups did not show differences in self-efficacy at 
discharge, ( d) those who abstained did show higher follow-up self-efficacy scores than 
those who had relapsed, and ( e) more than half of those who relapsed had correctly 
identified the circumstances surrounding their relapse. Although Burling et al. questioned 
the reliability of the self-efficacy ratings given by their patients, their results do not conflict 
with research in smoking cessation, and it seems equally likely that other methodological 
factors - such as the low percentage of follow-ups successfully completed over a six-
month period - may have created problems in their study. 
Solomon and Annis (1990) looked at the relationship between self-efficacy and 
outcome expectancies for 100 men in residential alcoholism treatment and at a three-
month follow-up. They were particularly interested in comparing self-efficacy as measured 
by the SCQ to the predictive validity of their outcome expectancy scales, which were 
constructed in a way similar to the pros and cons scales of Velicer et al. (1990). These 
investigators collected both types of expectancy measures at intake and again at three 
months after discharge, comparing them to measures of the quantity and frequency of 
alcohol consumption at follow-up. They found that SCQ scores improved from baseline to 
follow-up, while the outcome expectancy measures did not. Overall, they found no 
relationship between their follow-up measures and either outcome expectancy or self-
efficacy, but when restricted to those who drank at follow-up, the SCQ was found to 
account for 16% of the variance in quantity/frequency. Comparing three models of self-
efficacy and outcome expectancy effects, they rejected a multiplicative combinatorial 
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model and a model of parallel influence, concluding that their data best supported a model 
in which outcome expectancies were positively correlated with self-efficacy but did not 
provide incremental predictive power. 
Examining the stages of change model (Prochaska & DiClemente, 1982) in relation 
to attendance at Alcoholics Anonymous (AA), Snow, Prochaska, and Rossi (1994) 
questioned 191 abstinent individuals who had once had drinking problems. They wanted 
to assess processes of change, compare self-changers to those who attended AA, and 
examine whether or not levels of AA involvement were associated with distinct patterns of 
personal characteristics. In addition to other measures, participants completed a self-
efficacy scale sent to them by mail. Results showed no differences in self-efficacy levels by 
categories of AA attendance, nor were differences in self-efficacy found for those at 
various stages of change, even when AA attendance was used as a covariate. It should be 
noted, however, that this was an entirely retrospective study in which the sample was 
restricted to those who had been abstinent for some time. 
Finally, Di Clemente, Carbonari, Montgomery, and Hughes (I 994), in an attempt to 
validate their newly-created alcohol abstinence self-efficacy scale, compared several self-
efficacy factor models using the self-reports of 266 outpatient alcoholics. They found that 
a four-factor solution fit their instrument best, demonstrating good reliability and 
discriminant validity, although no measures of predictive validity were reported. 
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Hypotheses of the Present Study 
The paucity of self-efficacy applications in the area of treatment for alcohol and 
drugs other than nicotine should be apparent from this brief review. This situation is 
somewhat surprising given the central role this construct is thought to play in models such 
as the stages of change (Prochaska & DiClemente, 1982) and relapse prevention (Annis, 
1986; Marlatt, 1985) approaches. Clearly, additional work in this area is called for, and the 
present study was designed in part to address this issue. 
In the model proposed here, MMCD treatment is seen as an amalgam of 
motivational interventions, enforced abstinence, and skills training that affects outcome 
after discharge primarily by enhancing alcohol abstinence self-efficacy. Based on this view 
ofMMCD treatment, it was hypothesized that to the extent that the individual participates 
in the treatment process, he or she would be exposed to treatment components (e.g., 
persuasion, models, cognitive elaboration, visceral reactions, skills training) that increase 
self-efficacy to abstain from alcohol/drug use. Given these two intermediate processes 
(i.e., participation and self-efficacy change), it was predicted that increased abstinence 
self-efficacy (confidence) would result in persistence in alternative coping behaviors and 
enhancement strategies after discharge. In other words, higher abstinence self-efficacy at 
discharge was expected to forestall a return to alcohol use, which would be manifested as 
increased relapse latency - i.e., longer time to first use after discharge from treatment. 
Overview of the Proposed Model 
CHAPTER4 
METHOD 
The hypothesized model includes both a measurement model and a path model. 
The measurement model constitutes a set of confirmatory factor analyses for three of the 
four data collection panels (i.e., baseline, process, and discharge). The path model consists 
of two interlocking mediation analyses involving the following questions: (a) Does 
participation in treatment increase self-efficacy at discharge, controlling for prior levels of 
risk? and (b) To what extent does self-efficacy at discharge mediate the effect of 
participation during treatment on outcome after discharge? 
The measurement model. Based on previous research (cf, Cooper, Frone, Russell, 
& Mudar, 1995; Parrella, l 996a, l 996b ), risk of use - the first data collection panel, 
corresponding to baseline - was conceptualized in this study as a second-order factor 
underlying two types of positive outcome expectancies motivating alcohol use: coping 
expectancies and enhancement expectancies. Coping is defined here as use of alcohol to 
escape, avoid, or otherwise regulate negative emotional, interpersonal, and physical states, 
while enhancement is defined as alcohol use in the service of increasing positive emotional 
or social experience. Based on an assessment of the frequency of alcohol use in coping and 
enhancement situations in the six months prior to treatment entry, risk was considered an 
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index of the degree to which positive outcome expectancies drove pre-treatment alcohol 
consumption. 
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Since abstinence-oriented MMCD treatment programs are thought to have their 
effects by engaging patients in a self-directed change process under the guidance of 
counselors and peer role models, participation - the second data collection panel, 
corresponding to treatment process - was conceptualized here as consisting of 
involvement in the daily activities of the program, paying attention to educational materials 
such as lectures and films, and contributing during effortful activities and insight-oriented 
groups. Under the assumption that the active ingredients ofMMCD treatment (i.e., 
elements corresponding to Bandura's (1977) four sources of self-efficacy information) are 
stochastically distributed among the various activities, materials and experiences 
encountered during the treatment stay, participation served in this study as a control for 
patient motivation, compliance, and within-treatment self-selectivity. 
Alcohol abstinence self-efficacy, or confidence - the third data collection panel, 
corresponding to discharge - was, like risk, considered to be a second-order factor 
underlying abstinence self-efficacy in coping and enhancement situations. Since the 
referents for these two constructs (risk and confidence) are exhaustive and mutually 
exclusive behavioral alternatives (i.e., use versus abstinence), risk and confidence were 
conceptualized as reciprocally related: high risk of use implies low confidence to abstain 
from use, and vice versa. Just as risk - i.e., expectancies about the value of alcohol use as 
a method of coping with negative experience or enhancing positive experience - drives 
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consumption and indexes the likelihood of continued drinking, confidence (self-efficacy to 
abstain from alcohol use in coping and enhancement situations) is seen as driving 
abstinence, making it useful as a predictor of the likelihood of continued abstinence. Like 
participation, which was used to operationalize motivation and the self-selective treatment 
implementation that presumably results, confidence was used to operationalize a second 
factor critical to assessment ofMMCD effects, the extent to which the "conversion" 
process believed to mediate treatment outcome occurred. Since risk and confidence were 
considered to be reciprocally related, these concepts were treated as negatively correlated 
indices of self-efficacy to abstain from substance use. Furthermore, since the instruments 
used to collect risk and confidence self-assessments were congeneric measures with 
parallel scale structures, correlated errors of measurement were anticipated. 
Outcome, the fourth and final data collection panel, was defined primarily as the 
length of time to first use of alcohol or drugs after discharge. Research suggests that about 
two-thirds of all those who return to alcohol or drug use after treatment do so within the 
first six months after discharge (cf, Hunt, Barnett, & Branch, 1971 ). In this study, time to 
first use (latency) was defined as the number of weeks that elapsed within the six-month 
follow-up span before the use of alcohol or drugs first occurred. Since latency was 
measured with a single observed indicator in this study (i.e., self-report of time to first use 
at follow-up), a sensitivity analysis (cf, Marsh, 1990) was employed, rather than a 
confirmatory factor analysis, for this data collection panel. 
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The path model. The pair of interlocking mediational processes hypothesized to 
transmit MMCD treatment effects are described below. Figure 2 depicts the fully saturated 
path model on which this chain of transmission was based, with direct paths labeled for 
reference in the discussion that follows. The first mediational analysis is represented by 
paths A, B, and C, constituting, respectively: (a) the effect of prior risk on participation in 
treatment; (b) the effect of risk on confidence, controlling for participation; and ( c) the 
effect of participation in treatment on confidence at discharge, controlling for prior risk. 
Path A in this model indicates the extent to which positive expectations of use affect 
participation in treatment. It was hypothesized that this effect would be negative. Path B 
represents the stability of self-efficacy over time. Since risk and confidence were 
postulated to be reciprocally related, it was hypothesized that path B would also be 
negative. Path C, representing the effect of participation in MMCD treatment on self-
efficacy at discharge, was predicted to be positive. Taken together, paths A, B, and C 
addressed the question "Does participation in treatment influence self-efficacy at discharge 
once the effects of prior risk have been controlled?" 
Paths C, D, and E constitute the second set of mediational pathways. As noted 
above, path C, the direct effect of participation in treatment on self-efficacy at discharge, 
was predicted to be positive. Path D assesses the degree to which abstinence self-efficacy 
predicts the latency of subsequent alcohol/drug use. Since this has been demonstrated in 
prior smoking cessation research, it was predicted that this path would have a positive 
coefficient. Path E, representing the effect of participation on outcome not mediated by 
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self-efficacy, was also hypothesized to be positive. Taken together, paths C, D, and E 
addressed the question "To what extent are effects on outcome that can be attributed to 
treatment participation mediated by self-efficacy?" 
Figure 2 
Saturated Latent Variable Path Model 
Note. Circles indicate latent variables and arrows represent causal pathways. Letters A - F 
refer to direct effects discussed in the text. Risk = risk of use; Participation = participation 
in treatment; Confidence = abstinence self-efficacy; Latency = time to first use. 
The final direct path contained in the saturated model, path F, is the residual effect 
of risk on relapse latency, controlling for participation and self-efficacy. Like other paths 
emanating from risk, this effect was predicted to be negative. Two total effects, not 
labeled in Figure 2, were also of interest. These were: (g) the total effect of participation 
on outcome (i.e., the direct effect in path E, plus the indirect effect represented by the 
product of paths C and D); and (h) the total effect of risk on outcome (i.e., the direct 
effect of path F plus the indirect effects represented by A*C*D, A*E, and B*D). 
Subjects 
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Subjects were 109 men and women who had been admitted as inpatients to a large 
Midwestern substance abuse hospital for treatment of their alcohol abuse (and, in some 
cases, for the abuse of other drugs as well as alcohol). Study subjects were all volunteers 
who participated in a larger study of treatment process issues (see Procedures, below). All 
volunteers for the larger study were included in the present sample, providing they met the 
following conditions: (a) they reported use of alcohol in the month prior to treatment, 
(b) there was no evidence of coexisting eating disorders, and ( c) they completed all four of 
the instruments used in this study (see Measures, below). The first two conditions were 
employed to reduce the heterogeneity of the sample and ensure significant alcohol 
involvement on the part of study participants. The third condition was required because 
the main focus of the present study was an analysis of the covariation of self-efficacy, 
participation in treatment, and outcome at six months after discharge. 
The 109 individuals who met these conditions (71 men, 65%, and 3 8 women, 
35%) ranged in age from 20 to 74 (M= 39.7, SD= 12.4); twenty-five percent (25%) were 
under 30, and 27% were over 45. Most (98%) were white, 42% were married, and 25% 
were living alone at the time of admission. Eighty-five percent (85%) of subjects were 
high school graduates, and 60% were employed full time. This was the first treatment 
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episode for 54%, and 29% reported a positive family history of alcohol and/or other drug 
abuse treatment. 
Procedures 
All data used in the present study were obtained from an archival data set derived 
from a two-year study of alcoholism treatment, the Treatment Process Study (TPS; 
Parrella, Filstead & Ross, 1993), which was funded by the National Institute on Alcohol 
Abuse and Alcoholism (NIAAA; Grant No. 08455). The principal investigator for the TPS 
granted the present author access to selected portions of the TPS data set for the purpose 
of conducting the research described here. 
Overview of the TPS. The TPS was designed to operationalize the components 
and processes of treatment in a standard, abstinence-oriented, inpatient treatment program 
patterned after the Minnesota model (Cook, 1988a, 1988b ). The overall aim of the TPS 
was to construct a detailed "map" of treatment processes in terms of the activities and 
services constituting treatment on a day-to-day basis. The main goals of the study were to 
examine whether or not all patients got the same types and amounts of services, and to 
explore perceptions, motivation, effort, and mood changes during the program. The TPS 
included measures of pre-treatment expectations, differential service utilization during 
treatment, perceived program difficulty, and the impact of individual service components. 
These data were collected in face-to-face interviews and self-report questionnaires filled 
out at baseline and discharge, and by means of a self-monitoring workbook (the Treatment 
Experience Workbook, TEW) that patients filled out each night during treatment at the 
end of the day before they went to bed. 
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Treatment program characteristics and operation. The treatment facility at which 
the TP S was conducted was a licensed, 104-bed substance abuse hospital admitting about 
1800 patients a year. During the TPS, approximately forty percent (40%) of admissions 
were referred out to other programs or services after a 3-5 day detoxification period. 
Most of those who remained stayed from 2-4 weeks and received care in an abstinence-
oriented, educational MMCD program predicated on the disease model of addiction and 
the 12-step self-help philosophy of Alcoholics Anonymous. Treatment services offered at 
this site included focus groups, lectures, films, medical care, psychiatric management, 
medication, recreational activities, self-help literature, individual counseling, group and 
family therapy, employer conferences, and self-help group meetings. 
TPS procedures. Within 24 hours of admission, all new patients were solicited for 
participation in the TPS. A short video was shown on the detoxification and assessment 
units describing the purposes and procedures of the study. The principal investigator for 
the TPS attended these sessions and answered questions raised by patients. Those who 
agreed to participate were asked to read and sign a consent form and provide additional 
information to enable follow-up after discharge. Then, over the course of the next two 
days, study participants were interviewed and asked to complete several questionnaires in 
addition to the standard battery of tests obtained for clinical use. 
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During the initial testing session, study participants were given the first of a series 
of workbooks (TEW) containing forms for daily self-monitoring. They were instructed in 
the use of the workbook in face-to-face interviews and asked to go through a "dry run" in 
which they reconstructed the previous day's activities and experiences. Subjects returned 
to the research center on the second day to complete the remaining TPS instruments and 
review the first day of in situ use of the workbook. Although invited to return to the 
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research center at any time, especially if they had questions, subjects were scheduled to 
return once each week to get a new workbook, review the one they turned in, and clarify 
questions about program activities or completion of workbook sheets. Just before 
discharge, they came to the research center again to turn in their final workbook and 
complete retest versions of baseline instruments. 
At the scheduled six-month follow-up, those who gave consent for follow-up were 
called by interviewers in the attempt to locate them and conduct a telephone interview. 
The study protocol called for 15 phone call attempts per subject, spread over various 
times of the day and various days of the week. If phone contacts were unsuccessful, two 
attempts were made to contact subjects through the mail. A span of one month after the 
scheduled follow-up date was allowed for contact. If phone and mail contact attempts 
failed, subjects were coded as "lost." If contacts succeeded but subjects refused 
participation, they were dropped from the follow-up and coded as "refusers." If subjects 
consented to be interviewed, a l 5-to-30 minute structured follow-up interview was 
conducted over the phone. 
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Interviews were conducted by trained interviewers using structured interview 
guides. Questions were framed concerning the six-month period "since discharge." 
Subjects were assured of their confidentiality, asked to confirm the collateral information 
provided on the consent form signed during treatment, and permission was requested to 
contact collaterals. Subjects were then guided through a self-assessment of compliance 
with discharge recommendations, self-help involvement, contact with treatment agencies, 
and incidents of alcohol and drug use, including multiple substances and patterns of use. If 
the subject was part of the group randomly selected for an interrater reliability substudy, 
he or she was also asked to consent to be re-interviewed. 
Additional procedures for the present study. To obtain data for the present study 
from the TPS archive, administrative records were used to determine which subjects met 
the three conditions outlined above (viz., alcohol use, no concurrent eating disorders, and 
presence of the instruments used in this study). In order to protect the confidentiality of 
TPS participants, all information used to identify individual subjects was removed from the 
portion of the TPS data base used in this project. 
Measures 
Demographic and clinical variables. Demographic and clinical information was 
taken from the TPS administrative record and from the Alcohol and Substance Abuse 
Questionnaire (ASAQ; Parrella, Filstead & Ross, 1990), a 16-section paper-and-pencil 
self-report instrument. The ASAQ provides an overview of demographics, the historical 
development of alcohol and substance use patterns, prior treatment history and family 
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history of treatment, quantity and frequency measures for alcohol and other drugs, and 
psychosocial, physiological, and behavioral measures of consequences due to alcohol and 
other drug use. For this study, only the sample descriptors listed under Subjects, above, 
were abstracted. 
Panel 1: Risk. Utilizing Bandura's (1977, 1986) explication of self-efficacy and 
Marlatt's (1985) analysis of the relapse process, Annis (1986) proposed a relapse 
prevention model for treatment of alcoholics based on the idea that treatment will be 
effective to the extent it increases self-efficacy to abstain from alcohol use in alcohol-
related situations in the natural environment. To provide a target for efforts directed at 
improving self-efficacy, this approach begins with a highly detailed microanalysis of risk 
situations. The result of this microanalysis constitutes a classic functional analysis 
(Bootzin, 197 5) of drinking behavior, generating an individualized hierarchy of risk areas 
for use in treatment planning and revealing the strength of alcohol outcome expectancies 
on the basis of situation-specific assessments of habit strength or risk of use. 
The 100-item questionnaire used to conduct this functional microanalysis, the 
Inventory of Drinking Situations (IDS), was designed to assess situations in which the 
client drank heavily over the past year. Annis's (1986) development of the IDS drew upon 
several sources, including discussions with clinicians and alcoholics. As recommended by 
Bandura (1977) and others (e.g., Ajzen & Fishbein, 1977), IDS risk assessments are made 
with respect to highly specific situations. The final set of items comprises eight categories, 
divided into two major classes: intrapersonal states, where drinking occurs in response to 
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an event that is primarily psychological or physical in nature; and interpersonal states, 
where a significant influence of another individual is involved. The five subscales classified 
as intrapersonal are: negative emotional states (NES); negative physical states (NPS); 
positive emotional states (PES); testing personal control (TPC); and urges/temptations 
(U/T). The three interpersonal subscales are: interpersonal conflict (IPC), social pressure 
to drink (SP), and positive social situations (PSS). This classification scheme was derived 
largely from Marlatt' s ( 1985) content analysis of interviews with chronic male alcoholics 
about the circumstances surrounding their first relapse after alcoholism treatment. 
The variant of this questionnaire used in the present study, the Inventory of 
Drinking and Drug Situations (IDDS), was a modification of the instrument developed by 
Annis (1986), used with her permission. The IDDS content was identical to the IDS, 
except that the instructions and individual items were modified to refer to situations of 
heavy drinking and/or drug use. The IDDS used in this study was administered as a paper-
and-pencil self-report, in which the individual indicated the frequency with which he/she 
drank or used drugs heavily over the past year, for each of 100 situations, using a four-
point rating scale (I =never, 2 =rarely, 3 =often, and 4 =almost always). The eight 
subscale scores corresponding to the categories listed above were obtained by adding 
responses within each category. These subscales can be used in raw form, or they can be 
converted to problem indices, calculated as percentages of maximum scale value. The 
problem index scores, each ranging from 0 (no risk) to 100 (high risk), were used in the 
present investigation, and two of the subscales, TPC and U/T, were omitted from the 
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analysis, since preliminary work suggested a higher degree of factor complexity for these 
scales than for the remaining six (cf Parrella, l 996a}. 
Panel 2: Participation. Participation scores were derived from TEW sheets. Since 
abstinence-oriented MMCD treatment involves engaging patients in a self-directed change 
process under the guidance of counselors and peer role models, participation was 
conceptualized as a multidimensional variable consisting of participating in the daily 
activities of the treatment program, paying attention to educational materials such as 
lectures and films, and contributing during insight-oriented group activities. The items 
comprising the participation index are listed in Table I. Each item was answered on a six-
point scale anchored with the labels I = not at all and 6 = very or very much. 
Table I 
Participation Items 
How much effort did you put into treatment today overall? 
How hard did you work today? 
Were you interested and paying attention? 
Were you motivated? 
How much did you participate in today's treatment activities? 
Did you contribute when you were in groups? 
Although a participation score could, in theory, have been calculated for each day 
of inpatient treatment, program activities were concentrated on weekdays, so attention 
was restricted to TEW sheets completed Monday through Friday. Furthermore, since 
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individual patients within this sample remained in treatment for varying lengths of time, 
summary participation scores computed across the full length of stay might have unfairly 
weighted the scores of some subjects over others. Thus, the approach taken here involved 
computing mean participation item values for all valid non-weekend sheets completed 
during the first five weekdays in active treatment (i.e., the first five non-weekend days 
after the period of detoxification). Besides equating subjects in terms of the span over 
which participation was calculated, this procedure was considered advantageous in that it 
represents an assessment of participation early in treatment, during a critical phase of 
program activities. To examine the effect of this computational procedure on study 
findings, results were compared to those obtained using participation scores computed 
from all non-weekend sheets across the full length of stay, and length of stay itself 
(measured in days) was examined as an alternative means of operationalizing participation. 
Panel 3: Confidence. Annis' s ( 1986) Situational Confidence Questionnaire (SCQ) 
was developed as a companion instrument to the IDS, containing 100 parallel items used 
to assess Bandura' s ( 1977) concept of self-efficacy with regard to the perceived ability to 
cope with alcohol. Individuals are instructed to imagine themselves in each situation and 
to rate how confident they are that they would be able to resist the urge to drink heavily in 
that situation. SCQ responses are given on a six-point "percent confident" rating scale (0, 
20, 40, 60 , 80, 100, where 0% and 100% are anchored with the labels 0 = not at all 
confident and 100 = very confident). SCQ scales are organized into the same eight areas 
as the IDS (i.e., NES, NPS, PES, TPC, U/T, IPC, SP, and PSS), but following Bandura 
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( 1977), three types of scores can be computed for each category: (a) self-efficacy level, 
defined as the number of items with ratings of 60% or higher; (b) self-efficacy strength, 
defined as the sum of items within the scale; and ( c) self-efficacy generality, calculated as 
the correlation of the strength score across categories. 
The SCQ variant employed in the present study was a modification of Annis' s 
(1986) instrument, used with her permission. The SCQ used here was identical to Annis' s 
version in content, except that instructions and individual items were modified to refer to 
situations of heavy drinking and/or drug use. In addition, because the treatment program 
was abstinence-oriented, Annis' s instructions were also modified to read "resist the urge 
to drink or use drugs," instead of"resist the urge to drink heavily." In this investigation, 
self-efficacy strength scores were used, and these were converted to the same 0-100 
problem index metric applied to the IDDS. As with the IDDS, two SCQ subscales (TPC 
and U/T) were excluded from analyses, since preliminary work suggested a higher degree 
of factor complexity for these scales than for the remaining six (Parrella, l 986b ). 
Panel 4: Outcome. Two measures of treatment outcome were taken directly from 
self-reports on the six-month follow-up interviews: relapse status and relapse latency. 
Both outcome measures were used as a gauge of persistence in efforts to abstain from 
alcohol and drug use. The status variable indicated whether or not the individual reported 
any drinking or drug use after discharge, and was coded simply as 0 (abstinence) or 1 
(substance use). Relapse latency was defined as the amount of time, in weeks, between 
discharge and the first use of alcohol and/or other drugs after discharge. To control for 
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minor variability in the time span over which six-month follow-up data were collected, 
latency was converted to a 0-100% metric reflecting the amount of the follow-up time 
span that elapsed before first use, with shorter latency values representing earlier time to 
first use. All abstinent subjects were assigned a value of 100% for latency, indicating the 
maximum possible time to first use (i.e., since abstinent individuals did not use alcohol or 
drugs, post-discharge substance use remained entirely latent). As a check on this coding 
procedure, all analyses were repeated using raw latency scores (i.e., time to first use in 
weeks), yielding essentially identical results. 
Supplementary measures. One other workbook variable, the mean number of topic 
groups attended per day during the first week of treatment (NTOPIC), was also included 
in this study for the purpose of conducting supplementary analyses. Six topic groups were 
included in this count: (a) seminar, (b) bridge group, (c) compulsive behavior focus group, 
(d) leisure counseling, (e) relapse focus group, and (f) spiritual growth. For each daily 
workbook sheet, study participants indicated whether or not they attended each group, 
and the daily topic score was a simple count of the number of groups attended that day. 
The value used in this study - NTOPIC, the mean number of daily topic groups in the 
first week of treatment - was considered an alternative measure of treatment exposure, 
comprising that set of optional treatment-related discussion groups using more highly 
personalized and individualized methods, such as role-playing, to focus on recovery-
related issues. Like participation, the NTOPIC score was calculated as a mean of the daily 
topic scores from all valid non-weekend sheets completed during the first five weekdays in 
active treatment, but this procedure yielded a single NTOPIC value, rather than a set of 
six items. 
Data Analyses 
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Preliminaries. All analyses were conducted with the SPSS implementation of 
LISREL 7.2 (foreskog & Sorbom, 1989). Prior to formal analyses, all data were assessed 
in terms of distributional properties, particularly deviations from normality and excessive 
kurtosis, which affect the suitability of variables for inclusion in covariance structure 
analysis. Maximum likelihood estimation was used to derive all factor and path models, 
and a per-comparison alpha level of .05 was used within each analysis block to assess 
statistical significance for likelihood ratio (LR) step tests and model chi-square values (see 
below). Given the relatively small number of subjects, no alpha adjustment was applied to 
correct for the number of tests performed, since power to detect small effects given the 
size of the sample was low. All conclusions were also assessed at the .10 alpha level, and 
differences found are noted. Although covariance matrices were used as input for all 
analyses, completely standardized parameter estimates are reported here for ease of 
interpretation. 
Assessment criteria. The usual logic of significance testing is reversed in evaluating 
the overall fit of covariance structure models. That is, a non-significant chi-square value 
indicates that it is reasonable to accept the hypothesis that the constraints imposed by the 
model are valid. Since the chi-square is an omnibus test of the hypothesis that the residuals 
(the differences between the observed and model-implied parameters) do not differ 
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significantly from zero, non-significance indicates that the proposed model represents a 
plausible account of the processes that generated the observed data (Bollen, 1989). 
However, this use of the chi-square statistic has disadvantages that make assessing 
goodness-of-fit problematic. In particular: (a) it depends on a number of assumptions that 
are unlikely to be satisfied in practice (Bollen, 1989); and (b) chi-square values increase 
with increasing sample size, so a model may be rejected in large samples even if it 
represents the data well, while insufficient power may lead to inflated Type II error in 
small samples (Tanaka, 1993). 
Several investigators have called for a deemphasis on the dichotomous decision 
strategy epitomized by the classical hypothesis testing approach and a greater emphasis on 
measures of comparative fit in evaluating covariance structure models (e.g., Bentler & 
Bonnett, 1980; Breckler, 1990; McDonald & Marsh, 1990; Tanaka, 1993). This strategy 
uses the fit of a baseline model - usually a "null" baseline in which all indicators are 
assumed to be uncorrelated - against which to compare the fit of alternative models. 
That strategy was adopted in the present investigation, but even so, there appears to be no 
entirely satisfactory and universally-accepted goodness-of-fit statistic (Tanaka, 1993). 
Accordingly, multiple indices were used in the present investigation as guidelines to 
evaluate the goodness-of-fit of the models examined. In addition to the chi-square value, 
degrees of freedom, chi-square goodness-of-fit (GFI) statistic, and root mean square 
residual (RMR) produced by LISREL, the following additional indices are reported: 
(a) the ratio of the chi-square value divided by its degrees of freedom, (b) the nonnormed 
fit index (NNFI; Tucker & Lewis, 1973; Bentler & Bonnett, 1980), (c) the normed fit 
index (NFI; Bentler & Bonnett, 1980), ( d) the incremental fit index (IFI; Bollen, 1989), 
and (e) the comparative fit index (CFI; Bentler, 1990). 
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A cursory overview of fit statistics presented in recent published reports of 
covariance structure models shows wide variation and no consistent pattern, although 
Tanaka (1993) provides an interesting approach to their classification. A complete account 
of comparative fit indices is beyond the scope of this paper, but a brief overview of those 
used here follows. 
1. Since the expected value of a chi-square variate is its degrees of freedom, the 
chi-square/df ratio evaluates how many times larger the chi-square estimate is than its 
expected value. There is no consensus on what represents "good" fit using this index, 
however, and proposed values range from 5 on down. 
2. The NNFI takes into account sample size effects and it shows good 
performance as values approach one, but it can be anomalously small, especially in large 
samples. Furthermore, its sampling variability is substantially larger than some of the other 
indices, and since it is not normed, it can fall outside the O-to-1 range, making 
interpretation difficult. 
3. The NFI represents the incremental improvement in fit of the alternative model 
relative to the baseline in a standard metric ranging from 0 to 1. The NFI does not control 
for degrees of freedom, however, so apparent improvements in fit can be obtained merely 
by adding parameters or "overfitting" the data. Also, the mean of the sampling distribution 
of the NFI is larger for big than for small samples, so larger samples may give the 
impression of better fit even if the identical model holds. In addition, the NFI may not 
reach one even if a model is correct, especially in small samples. 
4. The IFI takes degrees of freedom into account and lessens the dependence on 
sample size, but it is not normed to the O-to-1 range, and sample size does influence its 
calculation, such that the IFI is larger for small sample sizes than for big ones. 
5. The CFI is normed and has small sampling variability, but it appears to have a 
small downward bias. For more complete accounts of these benefits and drawbacks, the 
interested reader is referred to Bentler and Bonnett (1980), Bollen (1989), Breckler 
(1990), McDonald and Marsh (1990), and Tanaka (1993). 
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Stepped tests of nested models. Another strategy is applicable for testing nested 
models. A more restrictive model is nested within a less restrictive model if the two 
models are identical except for constraints in the more restrictive model setting some of its 
parameters to a constant or to some function of its free parameters (Bollen, 1989). For 
example, any version of the saturated path model described above in which a single path 
or set of paths has been constrained to zero is nested within the fully saturated path model, 
because such models are identical except for the constraints in the more restricted model 
setting paths to zero. When models are nested, the likelihood ratio (LR), or chi-square 
difference test, provides a test of significance of the added constraints. If the LR statistic is 
significant, this indicates that freeing the constraints that distinguish the more from the less 
restrictive model produces an improvement in fit, making it unlikely that the more 
restrictive model is correct. Thus, in addition to the adjunctive goodness-of-fit indices 
listed above, the LR statistic was also employed in this study to compare nested models. 
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Analysis block 1: Confirmatory factor analysis for data collection panels. In a 
previous investigation (Parrella, l 996a), the first of two studies showed that a correlated 
Coping and Enhancement factor solution with correlated measurement errors (labeled M4 
in that study) provided excellent fit for the six IDDS scales from a group of 453 inpatient 
alcohol and drug abusers tested at admission to treatment, whereas both a single-factor 
solution (labeled Ml) and a two-uncorrelated factors solution (labeled M2) did not. 
Although a correlated two-factor solution (M3) provided good fit, the M4 solution -
which included correlated errors designed to model potential method effects - produced 
a statistically significant increment in fit, and was judged to be supported best by the data. 
In the second study of that investigation, cross-validation of the M4 solution in an 
independent sample demonstrated invariance of form and factor loadings, but the 
hypothesis of invariance was rejected for latent variable covariances and observed variable 
measurement errors. In a related investigation (Parrella, l 996b ), invariance of the M4 
solution as applied to IDDS data was confirmed in a third sample, and the M4 solution 
was extended to the SCQ. The IDDS and SCQ factor solutions were then merged in a 
path analysis, demonstrating a high degree of fit, which improved significantly with the 
addition of correlated longitudinal errors between parallel IDDS and SCQ scales. 
Given the level of fit and stability across independent samples demonstrated for the 
M4 solution in previous investigations, the first analysis block in the present study applied 
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the M4 solution directly to the IDDS and SCQ data from subjects in this sample to test 
measurement hypotheses for these instruments. Goodness-of-fit for the M4 solution was 
assessed individually for the IDDS and SCQ by comparing each model to its respective 
null baseline, using the chi-square value and adjunctive fit indices described above. It was 
predicted that these two confirmatory factor analyses would show excellent fit for the M4 
factor solution as applied to IDDS and SCQ data from the present sample. 
A similar procedure was applied to the participation items. First, corresponding 
pairs of items were combined, yielding three indicators representing effort ("How much 
effort did you put into treatment today overall?" plus "How hard did you work today?"), 
motivation ("Were you interested and paying attention?" plus "Were you motivated?"), 
and participation ("How much did you participate in today's treatment activities?" plus 
"Did you contribute when you were in groups?"). Then a null baseline model was 
specified containing the three independent indicators and no common factors, against 
which the goodness-of-fit of the final Participation model was tested. Last, the 
Participation factor was specified as a single common factor on which all three indicators 
loaded. In order to provide a measurement scale for the latent variable, the loading of the 
indicator named participation was constrained to equal one (cf, Bollen, 1989). Since a 
three-indicator model with two free loadings is just identified, fitting the data perfectly and 
yielding a chi-square value of zero with no degrees of freedom, in order to conduct 
goodness-of-fit tests, this model was modified by constraining the effort indicator to equal 
one, as well (cf., Hayduk, 1987). Goodness-of-fit for this factor solution was assessed in 
comparison to the null baseline, using the chi-square value and adjunctive fit indices. It 
was predicted that the Participation factor derived in this way would fit the data well. 
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Analysis block 2: Testing paths in the saturated model. In order to assess the 
significance of the individual paths in the saturated model, the complete path model was 
examined in this set of analyses. Since the number of subjects in this study was small 
relative to the number of free parameters estimated in a path model using all variables, the 
Coping and Enhancement factors of the IDDS and SCQ were considered separately. Thus, 
two risk-participation-confidence-outcome (RPCO) path models were examined, each of 
which included three of the indicators from both the IDDS and SCQ: a RPCO model for 
Coping (using the NES, NPS, and IPC scales) and a RPCO model for Enhancement (using 
the PES, PSS, and SP scales). Parallel procedures were used to examine both models. 
First, a null baseline was specified for each RPCO model in which the 10 indicators 
(i.e., three IDDS scales, three Participation indicators, three SCQ scales, and the outcome 
indicator) were constrained to be uncorrelated. Then a fully constrained path model was 
specified in which factor models derived from the previous analysis block were applied to 
the data and all six of the predictive paths (i.e., paths A through F, as described above) 
were constrained to zero. Finally, six additional models were composed, each of which 
was generated by freeing one of the six paths individually while the remaining five paths 
were constrained to zero. To assess statistical significance, each of these six step models 
was compared to the nested fully constrained path model using the LR statistic. Once the 
path model had been "stepped" in this fashion, a final RPCO model was generated in 
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which only significant paths were retained. This final trimmed RPCO model was then 
compared to the null baseline model to assess goodness-of-fit, using both the chi-square 
statistic and the adjunctive goodness-of-fit indices. To repeat, this sequence was 
conducted separately for the Coping RPCO and the Enhancement RPCO, and these 
procedures were conducted twice, once using relapse status as the outcome measure and 
once using relapse latency as the outcome measure. The Appendix lists covariance 
matrices for RPCO models involving latency, along with the LISREL commands used to 
generate the baseline, unconstrained, and trimmed models for Coping and Enhancement. 
Analysis block 3: Power and sensitivity. Since the number of subjects in this study 
was relatively small, analyses were conducted to examine the power of statistical tests to 
detect predicted effects. In covariance structure models, power can be assessed for 
individual parameters (such as specific factor loadings, or the predictive paths described 
above), for groups of parameters, or for the model as a whole. Satorra and Saris (1985), 
JOreskog and Sorbom (1989), and Bollen (1989) describe and illustrate procedures 
traditionally used to estimate power in covariance structure analyses. Since power can 
only be computed in relation to a specific alternative, these procedures involve specifying 
parameter values for an alternative model, generating the covariance matrix for this model, 
analyzing the resulting covariance matrix under the original model, and using the resulting 
chi-square value to approximate the chi-square noncentrality parameter. This noncentrality 
parameter is then used in conjunction with tabled values of the noncentral chi-square 
distribution to estimate the power of a significance test at a given alpha level. 
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Power assessment using these traditional procedures is highly sensitive to each of 
the specific parameter values chosen for the alternative model, so testing power for even 
moderately complex models may involve assessing a large number of combinations of 
alternative parameter values. Furthermore, these techniques all evaluate the power for a 
test of exact fit for a specific model, even though a model that provides a close (rather 
than exact) approximation to real-world relationships is the best that can be realistically 
expected (cf, Browne & Cudek, 1993). MacCallum, Browne and Sugawara (1996) 
describe another method of testing power based on the root-mean-square error of 
approximation (RMSEA), an index that indicates the discrepancy of model fit per degree 
of freedom. Based on their own work and that of other investigators, these authors 
provide a set of guidelines for interpreting RMSEA, suggesting that values less than 0.05 
represent close fit, values from 0.05 to 0.08 represent fair fit, and values above 0.08 
indicate mediocre or poor fit. Using the RMSEA index and these cutoff ranges, 
MacCallum et al. provide procedures for computing power and determining the minimum 
number of subjects required to achieve a specified level of power. 
Both types of power analyses were conducted in the present investigation. For 
each of the predictive paths in the two final RPCO models involving latency, power to 
reject the null hypothesis that the path equaled zero given the alternative value dictated by 
the size of the parameter in the freely estimated solution was computed using traditional 
procedures. Since power depends in part on alpha, power was computed using a range of 
alpha levels to determine whether or not the resulting increase in power that would be 
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obtained using an alpha larger than . 05 would affect study conclusions. For the model as a 
whole, the RMSEA-based procedure was then applied to assess power under null 
hypotheses of exact, close, and fair fit. 
Outcome indicators in this study were inferred on the basis of responses to a single 
self-report item, time to first use. In order to examine the effects of varying the level of 
reliability for this indicator, a sensitivity analysis was conducted for relapse latency. In this 
analysis, the reliability of the latency indicator was fixed at each of several values (viz., 
I. 0, . 9, . 8, . 7, . 6, and . 5) and the two final RPCO models were re-estimated. Foil owing 
procedures illustrated by Bollen (I 989), Hayduk (1987), and Marsh (I 990), this was 
accomplished by fixing the latency error term to x times the variance of the observed 
latency indicator, where x was equal to one minus the reliability of the indicator. 
Analysis block 4: Supplementary analyses. A number of other analyses were 
conducted to examine the RPCO models. First, models were examined which included 
participation items computed across the entire length of stay in place of those computed 
based only on the first week of treatment. Second, length of stay itself (measured in days) 
was substituted for the Participation factor and the two final RPCO models were re-
estimated. Third, the mean number of topic groups attended per day during the first week 
of treatment (NTOPIC; see Measures, above) was included along with the Participation 
factor and the final resulting models were re-estimated. These model variants were 
evaluated in the same fashion described above for analysis blocks I and 2. 
CHAPTERS 
RESULTS 
Descriptive Statistics 
Table 2 lists means, standard deviations, and Cronbach's (1951) alpha for the 
IDDS and SCQ scales for study subjects. IDDS and SCQ scales ranged from 0 to 100, 
whereas the scale for participation items ranged from 1 to 6. For the six participation 
items computed over the first week of treatment, alpha was .92 (M= 4.5, SD= 0.72). 
When computed across length of stay, alpha for participation was . 94 (M = 4. 5, 
SD= 0.66). Subjects in this sample received, on average, 22.0 days of treatment (SD= 
7. 7), which includes a mean of 2.3 days of detoxification (SD= 3.0). 
Table 2 
Means, Standard Deviations and Alphas for IDDS and SCQ Scales 
IDDS SCQ 
Scale Items M SD Alpha M SD Alpha 
Negative emotional states (NES) 20 50.9 27.8 .97 77.8 19.0 .97 
Negative physical states (NPS) IO 36.5 25.9 .90 83.6 18.4 .92 
Positive emotional states (PES) 10 49.6 27.8 .93 84.6 19.0 .94 
Interpersonal conflict (IPC) 20 39.7 27.2 .97 81.5 18.3 .97 
Social pressure (SP) IO 50.1 30.5 .93 79.2 22.7 .95 
Positive social situations (PSS) 10 51.3 30.6 .95 82.7 19.2 .94 
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For the outcome measures, subjects had been out of treatment for a span of 205.3 
days on average at the time of the six-month follow-up contact (SD= 31.4), this mean 
being slightly longer than the expected six months. Sixty-nine (69) of those contacted 
reported no use of alcohol or drugs (63.3%), while 40 (36.7%) reported that some use 
had occurred since discharge. In absolute terms, those who reported use said that their 
first use episode occurred an average of 11.3 weeks after discharge (SD= 10. 7), with a 
minimum of 0 weeks (used immediately after discharge) and a maximum of 3 5 weeks. 
When converted to percentage values, and including those who remained abstinent and 
were assigned a value of 100 percent latency, subjects in this sample reported an average 
latency of 77.0 percent of the available follow-up span (SD= 36.4). This value is, of 
course, heavily weighted by those who remained abstinent. The average latency for those 
who had used was 35.7 percent of the follow-up span (SD= 32.3), with a median value of 
22.3 percent and a mode of zero. More than half of those who drank or used drugs did so 
within the first two months after discharge. Table 3 lists means, standard deviations, and 
zero-order correlations for the sixteen observed indicators used in this study. 
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Table 3 
Means, Standard Deviations and Zero-Order Correlations for Indicators (N = I 09) 
Indicator 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 
1. rNES 
2. rNPS 
3. rPES 
4.rIPC 
5. rSP 
6. rPSS 
7.EFF 
.000 .000 .000 .000 .000 .893 .161 .835 .105 .582 .642 .133 .193 .334 .361 
.796 .000 .000 .000 .000 .846 .356 .697 .046 .014 .307 .021 .030 .143 .952 
.516 .452 - .000 .000 .000 .253 .024 .206 .459 .898 .152 .263 .098 .070 .452 
.895 .753 .557 - .000 .000 .983 .125 .657 .121 .526 .356 .060 .184 .268 .773 
.525 .414 .695 .597 - .000 .226 .649 .369 .553 .969 .412 .232 .005 .073 .380 
.583 .436 .735 .631 .916 - .269 .811 .517 .539 .931 .362 .174 .025 .064 .549 
.013 .019 -.111 -.002 .117 .107 - .000 .000 .585 .573 .072 .728 .856 .460 .369 
8. MOT -.135 -.089 -.216 -.148 -.044 -.023 .731 .000 .877 .891 .330 .945 .612 .333 .235 
9. PAR -.020 .038 -.122 -.043 .087 .063 .778 .715 - .608 .776 .045 .685 .318 .275 .359 
10. cNES -.156 -.192 -.072 -.150 -.058 -.060 .053 .015 .050 .000 .000 .000 .000 .000 .088 
11. cNPS 
12. cPES 
13.cIPC 
-.053 -.235 -.013 -.061 .004 .008 .055 -.013 .028 .824 - .000 .000 .000 .000 .068 
-.045 -.099 -.138 -.089 -.079 -.088 .173 .094 .193 .742 .761 .000 .000 .000 .077 
-.145-.221-.108-.181-.115-.131 .034 .007 .039 .911 .857 .770 .000 .000 .038 
14. cSP -.126 -.208 -.160 -.128 -.270 -.215 .018 .049 .097 .736 .688 .709 .727 - .000 .143 
15. cPSS -.093 -.141 -.174 -.107 -.172 -.178 .072 .094 .106 .805 .777 .860 .821 .836 - .016 
16. TTFU -.088 -.006 -.073 -.028 -.085 -.058 .087 .115 .089 .164 .176 .170 .199 .141 .230 
M 50.9 36.5 49.6 39.7 50.1 51.3 4.5 4.6 4.5 77.8 83.6 84.6 81.5 79.2 82.7 77.0 
SD 27.8 25.9 27.8 27.2 30.5 30.6 .8 .8 .8 19.0 18.4 19.0 18.3 22.7 19.2 36.4 
Note. A dash ("-") indicates the diagonal; means, standard deviations, and correlations 
are below the diagonal; p values for two-tailed tests of significance of correlations are 
above the diagonal; small "r" prefix indicates IDDS scales, small "c" prefix indicates SCQ 
scales. NES =Negative Emotional States; NPS =Negative Physical States; PES = 
Positive Emotional States; IPC =Interpersonal Conflict; SP= Social Pressure; PSS= 
Positive Social Situations; EFF = Effort indicator; MOT = Motivation indicator; PAR = 
Participation indicator; TTFU =Time to First Use as percentage of follow-up span 
(Latency). 
IDDS Factors 
Goodness-of-fit indices for IDDS factor models are presented in Table 4. As 
expected, uncorrelated baseline models fit poorly, as demonstrated by the large and highly 
significant chi-square values. Statistics for the M4 solution containing correlated Coping 
and Enhancement factors and correlated method errors, on the other hand, provided 
excellent fit, as did the single-factor solutions for Coping and Enhancement considered 
separately. Figure 3 presents parameter estimates for the IDDS M4 solution. 
Table 4 
Goodness of Fit Summary for IDDS Factor Factor Models 
Factor Model x2 d[_ /!_ 2 GFI RMR X ldf NNFI NFI IFI CFI 
Both Coping and Enhancement (all six IDDS indicators) 
Uncorrelated baseline 631.4 15 .000 .320 445.4 42.1 
M4, 2 correlated factors 12.6 6 .050 .962 29.2 2.1 .98 .95 .99 .98 
Coping Only (NES, NPS, IPC) 
Uncorrelated baseline 285.4 3 .000 .428 421.9 95.1 
One Coping factor 2.0 1 .161 .988 25.4 2.0 .99 .98 1.0 .99 
Enhancement Only (PES, PSS, SP) 
Uncorrelated baseline 281.5 3 .000 .446 494.6 93.8 
One Enhancement factor 1.1 .307 .994 19.9 1.1 1.0 .99 1.0 .99 
Note. A dash("-") indicates not applicable; GFI = LISREL goodness of fit index; 
RMR = root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit 
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and 
CFI based on comparison to respective uncorrelated baseline. 
The total coefficient of determination for observed indicators in the IDDS M4 
solution was .998, with squared multiple correlations ranging from .57 to .96. This 
suggests that the six observed indicators were good measures of the latent Coping and 
Enhancement variables. 
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Figure 3 
Parameter Estimates for the IDDS M4 Solution 
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Note. Circles indicate latent variables and boxes represent observed indicators. Anchored 
singled-headed arrows represent factor loadings, double-headed arrows represent 
association with no causal direction assumed, and unanchored arrows represent error 
variance. NES =Negative Emotional States; NPS =Negative Physical States; IPC = 
Interpersonal Conflict; PES =Positive Emotional States; PSS =Positive Social Situations; 
SP = Social Pressure. All parameters are completely standardized estimates. 
Participation Factors 
Goodness-of-fit indices for Participation factor models are presented in Table 5. 
Again, as expected, the uncorrelated baseline models provided poor fit, whereas the 
single-factor solutions were well-supported. Figure 4 presents parameter estimates for the 
Participation solution using indicators from the first week of treatment. Results suggest 
that the three indicators were excellent indicators of the underlying Participation factor. 
Table 5 
Goodness of Fit Summary for Participation Factor Models 
Factor Model x2 d[_ !!. 2 GFI RMR X ldf NNFI NFI IFI CFI 
Participation in the first week 
Uncorrelated baseline 196.3 3 .000 .476 .327 65.4 
One factor .7 1 .390 .995 .019 .7 1.0 .99 1.0 .99 
Participation across length of stay 
Uncorrelated baseline 288.4 3 .000 .421 .290 96.1 
One factor .1 .795 .998 .004 .1 1.0 1.0 1.0 1.0 
Note. A dash("-") indicates not applicable; GFI = LISREL goodness of fit index; 
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit 
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and 
CFI based on comparison to respective uncorrelated baseline. 
Figure 4 
Parameter Estimates for the Week One Participation Solution 
.179 .331 .272 $$$ 
.906 .818 .853 
Note. Circles indicate latent variables and boxes represent observed indicators. Anchored 
singled-headed arrows represent factor loadings and unanchored arrows represent error 
variance. EFF = Effort indicator; MOT = Motivation indicator; PAR = Participation 
indicator. All parameters are completely standardized estimates. 
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SCO Factors 
Goodness-of-fit measures for the SCQ models are displayed in Table 6. As with 
the IDDS models, the uncorrelated baselines fit poorly while the hypothesized factor 
structures fit well. Note, however, that in the original Enhancement-only solution, the 
error variance for the PSS indicator was slightly negative, a condition known as a 
Heywood case. Bollen ( 1989) suggests a number of possible causes and solutions for such 
problems, one of which is to consider small negative values as essentially equal to zero. 
Some covariance structure analysis programs, such as EQS (Bentler, 1989), perform this 
adjustment automatically, preventing Heywood cases by holding ill-behaved parameters at 
the permissible boundary (e.g., fixing the value at zero). Since LISREL does not perform 
this correction automatically, the Enhancement only solution was respecified with the 
error term for PSS fixed at zero. This provided a good fit to the data in this case, although 
fixing a parameter in this way also yielded an extra degree of freedom for this model. 
While other solutions are available and should be considered - such as dropping the 
offending indicator - the size of the error term and the degree of fit for both the M4 
solution and the corrected Enhancement-only solution suggested that fixing the PSS error 
term at zero was the best approach in this case. 
As with the IDDS M4 solution, the total coefficient of determination for observed 
indicators in the SCQ M4 solution was very high (. 996). Squared multiple correlations 
ranged from .70 to .97, suggesting that the six observed indicators were very good 
measures of the latent Coping and Enhancement variables. 
Table 6 
Goodness of Fit Summary for SCQ Factor Models 
Factor Model 
2 d[ p GFI RMR X ldf NNFI NFI IFI CFI 
Both Coping and Enhancement (all six SCQ indicators) 
Uncorrelated baseline 760.8 15 .000 .242 251.1 50.7 
M4, 2 correlated factors 2.9 6 .823 .991 3.0 .5 1.0 .99 1.0 1.0 
Coping Only (NES, NPS, IPC) 
Uncorrelated baseline 
One Coping factor 
339.2 
.1 
Enhancement Only (PES, PSS, SP) 
Uncorrelated baseline 274.6 
One Enhancement factor .2 
3 .000 .401 210.9 113 
1 .947 1.0 .6 .1 1.0 1.0 1.0 1.0 
3 .000 .436 232.4 91.5 
2 . 91 7 . 999 6. 1 . 1 1. 0 1.0 1.0 1.0 
Note. A dash ("-") indicates not applicable; GFI = LISREL goodness of fit index; 
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit 
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and 
CFI based on comparison to respective uncorrelated baseline. 
Figure 5 presents parameter estimates for the SCQ M4 solution. Note that the 
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correlation between Coping and Enhancement factors was higher for the SCQ M4 solution 
than for that derived from the IDDS. This indicates that Coping and Enhancement 
abstinence self-efficacy categories may be less distinct (or, alternatively, more coherent) 
than the same categories applied to risk of use, replicating the results of previous research 
(Parrella, l 996b ). Overall, then, the confirmatory factor analyses conducted for the first 
three data collection panels provided strong support for the measurement hypotheses of 
this study, yielding a good foundation for considering the structural hypotheses 
represented by the path analyses. 
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Figure 5 
Parameter Estimates for the SCQ M4 Solution 
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Note. Circles indicate latent variables and boxes represent observed indicators. Anchored 
singled-headed arrows represent factor loadings, double-headed arrows represent 
association with no causal direction assumed, and unanchored arrows represent error 
variance. NES =Negative Emotional States; NPS = Negative Physical States; IPC = 
Interpersonal Conflict; PES =Positive Emotional States; PSS = Positive Social Situations; 
SP = Social Pressure. All parameters are completely standardized estimates. 
Path Tests and Final Models for Coping 
Goodness-of-fit indices for the Coping RPCO models using relapse status as the 
outcome measure are presented in Table 7, and comparisons among nested models 
comprising the six step tests for individual paths are presented in Table 8. As predicted, 
the uncorrelated baseline model provided poor fit, whereas the RPCO model fit the data 
well. Contrary to predictions, however, the null hypothesis could not be rejected for any of 
the six paths, as indicated by non-significant LR statistics for each of the stepped paths in 
Table 8. Thus, in this case, the final trimmed Coping RPCO using relapse status as the 
outcome indicator was the same as the fully constrained path model. 
Table 7 
Goodness of Fit for Coping RPCO Models Using Relapse Status 
Path Model x2 d[ /!_ 2 GFI RMR X ldf NNFI NFI IFI CFI 
Uncorrelated baseline 874.5 45 .000 .442 159.3 19.4 
RPCO, all paths constrained 28.9 33 .672 .952 30.1 .9 .97 .96 1.0 .97 
RPCO, trimmed 28.9 33 .672 .952 30.1 .9 .97 .96 1.0 .97 
Note. A dash("-") indicates not applicable; GFI = LISREL goodness of fit index; 
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit 
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and 
CFI based on comparison to uncorrelated baseline. 
Table 8 
Path Steps for Coping RPCO Model Using Relapse Status 
Model Com,earison LR d[ /!_ 
Constrained vs. free A 0.15 .699 
Constrained vs. free B 2.44 1 .118 
Constrained vs. free C 0.15 1 .699 
Constrained vs. free D 2.32 1 .128 
Constrained vs. free E 1.73 1 .188 
Constrained vs. free F 0.46 1 .498 
Note. LR = likelihood ratio test statistic 
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Goodness-of-fit measures for the Coping RPCO models using latency as the 
outcome measure are presented in Table 9, and comparisons among nested models for the 
six step tests are presented in Table 10. As for relapse status, the uncorrelated baseline 
model using latency provided poor fit, whereas the RPCO models fit the data well. 
Contrary to predictions, the null hypothesis could not be rejected for five of the six paths, 
as indicated by non-significant LR statistics. Freeing path D did provide an improvement 
in fit using . 05 as a cutoff for the LR statistic. Thus, the final trimmed model for the 
Coping RPCO path analysis using latency as the outcome measure contained only one 
freely estimated path, path D, predicting relapse latency from confidence at discharge. 
Table 9 
Goodness of Fit for Coping RPCO Models Using Latency 
Path Model x2 dl l!. 2 GFI RMR X ldf NNFI NFI IFI CFI 
Uncorrelated baseline 875.6 45 .000 .441 162.3 19.5 
RPCO, all paths constrained 30.0 33 .619 .951 43.3 .9 .97 .95 1.0 .97 
RPCO, trimmed 25.6 32 .779 .956 32.8 .8 .97 .96 1.0 .97 
Note. A dash ("-") indicates not applicable; GFI = LISREL goodness of fit index; 
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit 
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and 
CFI based on comparison to uncorrelated baseline. 
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Table 10 
Path Steps for Coping RPCO Model Using Latency 
Model Com2arison LR d[_ l!.. 
Constrained vs. free A 0.15 1 .699 
Constrained vs. free B 2.44 1 .118 
Constrained vs. free C 0.14 1 .708 
Constrained vs. free D 4.33 1 .037 
Constrained vs. free E 1.15 1 .284 
Constrained vs. free F 0.54 1 .462 
Note. LR = likelihood ratio test statistic 
Path Tests and Final Models for Enhancement 
Goodness-of-fit indices for the Enhancement RPCO models using relapse status as 
the outcome measure are presented in Table 11, and comparisons among nested models 
comprising the six step tests for individual paths are presented in Table 12. As with 
Coping, the uncorrelated baseline model for Enhancement provided poor fit, whereas the 
RPCO model fit the data much better. Contrary to predictions, the null hypothesis could 
not be rejected for five of the six individual paths. The significant path in this case was 
path B, the stability coefficient predicting confidence at discharge from risk at baseline. 
The final trimmed Enhancement RPCO model using relapse status as the outcome 
indicator included only path B, yielding a non-significant chi-square value for the trimmed 
path model. 
Table 11 
Goodness of Fit for Enhancement RPCO Models Using Relapse Status 
x2 2 Path Model d[_ !!. GFI RMR X ldf NNFI NFI IFI CFI 
Uncorrelated baseline 812.4 45 .000 .453 185.8 18.1 
RPCO, all paths constrained 47.9 33 .045 .918 40.4 1.5 .94 .92 .98 .94 
RPCO, trimmed 43.9 32 .078 .924 12.2 1.4 .95 .92 .98 .95 
Note. A dash ("-") indicates not applicable; GFI = LISREL goodness of fit index; 
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit 
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and 
CFI based on comparison to uncorrelated baseline. 
Table 12 
Path Steps for Enhancement RPCO Model Using Relapse Status 
Model Com2arison LR df_ l!. 
Constrained vs. free A 0.50 1 .480 
Constrained vs. free B 3.97 1 .046 
Constrained vs. free C 0.98 1 .322 
Constrained vs. free D 2.03 .154 
Constrained vs. free E 1.73 1 .188 
Constrained vs. free F 0.02 1 .888 
Note. LR= likelihood ratio test statistic 
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Goodness-of-fit for the Enhancement RPCO models using latency as the outcome 
measure are presented in Table 13, and comparisons among nested models for the six step 
tests are presented in Table 14. As in previous models, the uncorrelated baseline provided 
poor fit, whereas the RPCO models fit the data much better. Only two of the six paths 
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provided an improvement in fit, as indicated by significant LR statistics, when compared 
to the Enhancement RPCO model in which all paths were constrained to zero. Freeing 
path B and path D provided significant improvements in model fit. Thus, the final trimmed 
model for the Enhancement RPCO path analysis using latency as the outcome measure 
contained two freely estimated paths, path B (predicting confidence from prior risk) and 
path D (predicting latency from confidence). 
Table 13 
Goodness of Fit for Enhancement RPCO Models Using Latency 
x2 2 Path Model d[_ [!_ GFI RMR X ldf NNFI NFI IFI CFI 
Uncorrelated baseline 815.0 45 .000 .451 189.3 18.1 
RPCO, all paths constrained 50.5 33 .027 .914 54.2 1.5 .94 .92 .98 .94 
RPCO, trimmed 40.8 31 .112 .930 16.3 1.3 .95 .93 .99 .95 
Note. A dash ("-") indicates not applicable; GFI = LISREL goodness of fit index; 
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit 
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and 
CFI based on comparison to uncorrelated baseline. 
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Table 14 
Path Steps for Enhancement RPCO Model Using Latency 
Model Com~arison LR df l!. 
Constrained vs. free A 0.49 1 .484 
Constrained vs. free B 3.96 1 .047 
Constrained vs. free C 0.97 1 .325 
Constrained vs. free D 5.77 1 .016 
Constrained vs. free E 1.15 1 .284 
Constrained vs. free F 0.42 1 .517 
Note. LR= likelihood ratio test statistic 
Power 
Table 15 displays the results of calculating power using traditional procedures for 
different alpha levels. The level indicated by the tabled value represents the power of the 
step tests to reject the null hypothesis that the specified path was equal to zero, given the 
size of the parameter in the freely estimated solution and the specified alpha level. These 
values correspond directly to the step comparisons reported above in Tables 10 and 14. As 
can be seen from an examination of Table 15, power for tests of paths retained in the two 
final trimmed RPCO models was acceptable, being above an admittedly somewhat 
arbitrary cutoff level of 0.40. While raising alpha as high as .25 would bring power to 
acceptable levels for four additional tests, this alpha level would affect the significance of 
only one path (the B path predicting confidence from risk in the Coping solution). 
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Table 15 
Power to Reject Null Hypothesis for RPCO Models Using Latency 
Al~ha 
Path Beta .05 .10 .15 .20 .25 
Coping RPCO model 
A -.041 0.07 0.13 0.18 0.23 0.29 
B -.153 0.34 0.46 0.55 0.61 0.66 
c .033 0.06 0.12 0.17 0.22 0.27 
D .192 0.51 0.63 0.71 0.76 0.80 
E .099 0.17 0.27 0.34 0.40 0.46 
F -.039 0.07 0.13 0.18 0.24 0.29 
Enhancement RPCO model 
A .073 0.11 0.19 0.25 0.31 0.37 
B -.200 0.55 0.67 0.74 0.79 0.83 
c .114 0.21 0.31 0.39 0.45 0.51 
D .212 0.60 0.71 0.78 0.82 0.86 
E .089 0.15 0.23 0.30 0.37 0.42 
F -.028 0.06 0.11 0.17 0.22 0.27 
Note. Beta = size of completely standardized path coefficient; 
Tabled values represent power to reject the null hypothesis that 
the specified path equals zero at the specified alpha level. 
Table 16 displays power levels for the overall chi-square test ofRPCO models that 
included latency, calculated using the RMSEA procedure and cutoff values specified by 
MacCallum et al. (1996). Since power varies depending on degrees of freedom as well as 
alpha level, power is displayed for RPCO models in which all paths were freely estimated 
(df= 27) as well as for the trimmed models (df = 32 for Coping and 31 for Enhancement, 
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but 32 was used in the power calculations for trimmed models). Using Maccallum et al. 's 
cutoff values, exact fit was defined here as the power of the chi-square test to detect the 
alternate hypothesis that RMSEA ~ 0.05 using a null hypothesis that fit was exact (i.e., 
RMSEA = 0). Similarly, close fit was defined as power to detect an alternate hypothesis 
that RMSEA ~ 0.08 under a null hypothesis that fit was close (RMSEA::;; 0.05). Fair fit 
was defined as power to detect the alternate hypothesis that RMSEA ~ 0.08 when the null 
hypothesis was fair fit (RMSEA < 0.08). 
Table 16 
Power at Specified Fit Levels for RPCO Models Using Latency 
AlQha 
Level of fit .05 .10 .15 .20 .25 
RPCO models with paths freely estimated 
Exact fit 0.27 0.39 0.48 0.56 0.62 
Close fit 0.35 0.48 0.58 0.65 0.71 
Fair fit 0.73 0.82 0.88 0.91 0.93 
RPCO models with non-significant paths trimmed 
Exact fit 0.24 0.36 0.45 0.53 0.59 
Close fit 0.31 0.44 0.54 0.61 0.67 
Fair fit 0.67 0.78 0.84 0.88 0.90 
Note. Exact fit= power to detect Ha: RMSEA ~ 0.05 when 
H 0 :RMSEA = O; Close fit = power to detect Ha: RMSEA ~ 
0.08 when H0:RMSEA::;; 0.05; Fair fit= power to detect Ha: 
RMSEA ~ 0.08 when H0:RMSEA < 0.08; Ho= null 
hypothesis; Ha= alternate hypothesis; RMSEA =root-mean-
square error of approximation. 
As noted previously, the hypothesis of exact fit is probably quite unrealistic for 
most real-world applications. Overall, power levels for tests ofRPCO model fit were 
considered acceptable. Based on tables presented by Maccallum et al., the minimum 
number of subjects required to obtain a power of 0.80 under null hypotheses of either 
close or exact fit would have been approximately 3 50, or three times the number of 
subjects actually obtained in the present study. 
Sensitivity 
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Results of the sensitivity analyses for the Coping and Enhancement RPCO models 
using latency as the outcome measure are presented in Table 17. As expected, none of the 
paths that did not directly impinge on latency (i.e., paths A, B, and C) were affected by 
these analyses. Paths D, E, and F - which comprise all the direct effects involving latency 
- varied in a systematic and logical fashion as the reliability of the latency indicator was 
modified. Since covariance structure analysis corrects effects for unreliability in the 
indicators, the result of decreasing levels of reliability was an increase in the size of the 
standardized path coefficient estimates, as expected. None of the significance levels for 
these parameters were affected by reliability manipulations, however. 
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Table 17 
Sensitivity of RPCO Path Coefficients to Varying Latency Reliability 
Path 
Latency Reliability A B c D E F 
Coping RPCO with freely-estimated paths 
1. 0 (original model) -.041 -.153 .033 .192 .099 -.039 
.9 -.041 -.153 .033 .203 .105 -.042 
.8 -.041 -.153 .033 .215 .111 -.044 
.7 -.041 -.153 .033 .230 .119 -.047 
.6 -.041 -.153 .033 .248 .128 -.051 
.5 -.041 -.153 .033 .272 .141 -.056 
Enhancement RPCO with freely-estimated paths 
1. 0 (original model) .073 -.200 .114 .212 .089 -.028 
.9 .073 -.200 .114 .224 .094 -.029 
.8 .073 -.200 .114 .237 .100 -.031 
.7 .073 -.200 .114 .253 .107 -.033 
.6 .073 -.200 .114 .274 .115 -.036 
.5 .073 -.200 .114 .300 .126 -.039 
Note. Latency reliability was varied by fixing the error term for the latency 
indicator to (one minus reliability) times the variance of the latency indicator. 
Model Variants Involving Length of Stay 
Two sets of analyses were conducted to examine the effects of length of stay on 
study conclusions. First, the Coping and Enhancement RPCO models were re-estimated 
using participation indicators computed across the length of stay. Second, length of stay 
itself was included to assess effects attributable to treatment duration. Procedures for 
examining these supplementary variables included free estimation of paths, as well as a full 
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series of step analyses parallel to those described previously. Results of these analyses 
were for all practical purposes identical to the original Coping and Enhancement RPCO 
models. Neither participation computed across the length of stay nor length of stay in days 
yielded significant paths beyond those present in the trimmed models described in Tables 
7, 9, 11 and 13, so these findings are not presented in further detail here. 
Model Variants Involving Topic Groups 
The final set of supplementary analyses concerned the effects of a secondary 
measure of treatment exposure, NTOPIC, the mean number of topic-oriented groups 
attended per day during the first week of treatment. As described previously, NTOPIC 
embodied a set of optional discussion groups in which highly personalized methods like 
role-playing were used to address recovery-related issues. In the supplementary analyses 
described here, NTOPIC was added to the two RPCO models using latency as the 
outcome measure, creating two risk/topic group/participation/confidence/outcome 
(RTPCO) models (one for Coping and one for Enhancement). In addition to the six paths 
A through F present in the original RPCO models, the R TPCO models had four new 
paths: A' (risk to NTOPIC), B' (NTOPIC to Participation), C' (NTOPIC to confidence), 
and E' (NTOPIC to Latency). Goodness-of-fit for the Coping and Enhancement RTPCO 
models are presented in Table 18, and the model comparisons constituting path steps are 
displayed in Table 19. 
Table 18 
Goodness ofFit for RTPCO Models 
Path Model x2 d[_ [!_ 2 GFI RMR X ldf NNFI NFI IFI CFI 
Coping 
Uncorrelated baseline 908.7 55 .000 .442 148.2 16.5 
RTPCO, constrained 63.1 43 .025 .911 39.6 1.5 .93 .91 .98 .93 
RTPCO, trimmed 34.7 41 .747 .946 29.9 .9 .96 .95 1.0 .96 
RTPCO, trimmed at 1.64 31.7 40 .821 .951 13.9 .8 .97 .95 1.0 .96 
Enhancement 
Uncorrelated baseline 839.1 5 5 . 000 .4 5 9 1 72. 8 15. 3 
R TPCO, constrained 74.6 43 .002 .894 49.5 1.7 .91 .89 .96 .91 
R TPCO, trimmed 48.5 40 .169 .925 14.8 1.2 .94 .92 .99 .94 
RTPCO, trimmed at 1.64 45.6 39.218 .929 15.3 1.2 .95 .92 .99 .95 
Note. A dash ("-") indicates not applicable; GFI = LISREL goodness of fit index; 
RMR =root mean square residual; NNFI = Nonnormed Fit Index; NFI =Normed Fit 
Index; IFI = Incremental Fit Index; CFI = Comparative Fit Index; NNFI, NFI, IFI and 
CFI based on comparison to respective uncorrelated baseline. 
Several things should be noted about the R TPCO solutions. First, results of the 
step tests for the six original paths (A through F) are almost identical to those derived in 
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the original latency-based RPCO models (compare to Tables IO and 14). Second, only one 
of the four new paths achieved significance at the .05 level (i.e., C', the path predicting 
discharge self-efficacy from NTOPIC), and this path was significant for both Coping and 
Enhancement. Third, the trimmed Coping model included two significant paths (path C' 
and path D, the latter predicting latency from discharge self-efficacy}, while the trimmed 
Enhancement model included three (path C', path D, and path B, predicting confidence at 
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discharge from risk at baseline). Thus, the resulting trimmed RTPCO models were the 
same as the trimmed RPCO models, with the exception of the addition of path C '. Fourth, 
the C' path was negative in both solutions, indicating that more exposure to topic groups 
served to lower self-efficacy at discharge - a result opposite in direction to the effect on 
self-efficacy predicted for the Participation factor. 
Table 19 
Path Steps for R TPCO Models 
CoEing Enhancement 
Model ComEarison LR d[ !!_ LR df !!_ 
Constrained vs. free A 0.15 1 .699 0.49 1 .484 
Constrained vs. free A' 0.00 1.00 0.21 1 .647 
Constrained vs. free B 2.43 1 .119 3.96 1 .047 
Constrained vs. free B' 1.23 1 .267 1.24 1 .265 
Constrained vs. free C 0.14 1 .708 0.97 1 .325 
Constrained vs. free C' 24.13 1 .000 14.93 1 .000 
Constrained vs. free D 4.32 1 .038 5.78 1 .016 
Constrained vs. free E 1.15 1 .264 1.15 1 .264 
Constrained vs. free E' 0.23 1 .632 0.24 1 .624 
Constrained vs. free F 0.54 1 .462 0.43 1 .512 
Trimmed vs. Trimmed at 1.64 2.93 1 .087 2.90 1 .089 
Note. LR = likelihood ratio test statistic 
Finally, an additional modification of the RTPCO models was assessed. 
Examination of the t values for path parameters in the fully saturated models supported the 
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results of the step tests reported in Table 19, with one exception for each model. 
Typically, a critical t of 2 is used to assess parameters for significance: parameters with 
cutoff t values of 2 or higher are generally considered significant at the . 05 level, and this 
means of assessing significance usually converges with the results of the chi-square 
difference (LR) tests, as found here. In this case, however, inclusion ofNTOPIC in the 
models produced t values above 1.64 (i.e., significance at the .10 level) for one additional 
parameter in each model. For Coping, the 1.64 t cutoff also led to significance for the B 
path (predicting confidence from risk). For Enhancement, the 1.64 cutoff led to inclusion 
of the C path (predicting confidence from Participation). Note that these result are not 
reflected by the LR tests of these paths in Table 19, where the steps in which these two 
additional paths were freed individually did not produce significant results at the . 10 level 
(although the p value for the B path in the Coping RTPCO, .119, is close to this level). It 
should also be noted that the marginal level of significance for these two additional paths 
was not the case for either of the RPCO models - in other words, results reported in 
Tables 9 and 10 (for Coping) and Tables 13 and 14 (for Enhancement) were the same 
whether a t cutoff of 2 or 1. 64 was used. 
Since the R TPCO results based on t values and the results based on LR step tests 
were divergent, and since the number of subjects available in this study led to relatively 
low power to detect effects, both models were re-estimated and examined using the results 
based on t values of 1.64. Table 18 lists these results as "RTPCO, trimmed at 1.64," and 
the last test shown in Table 19 provides additional comparisons in which the R TPCO 
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models with and without the borderline paths are compared. Table 18 shows a very minor 
improvement in fit for both models when the questionable paths are included. Table 19 
demonstrates that, in both cases, inclusion of these paths yields an improvement over the 
trimmed models significant at an alpha level of .10, which converges with the results of the 
t tests for these parameters. Completely standardized parameter estimates for the resulting 
R TPCO path models trimmed at 1. 64 are illustrated in Figure 6. Except for the paths 
involving NTOPIC, and the two additional paths that achieved significance at .10 when 
NTOPIC was included (i.e., path Bin the Coping model and path C in the Enhancement 
model), the parameter estimates reported in Figure 3 are very similar to those produced in 
the two final trimmed RPCO models (compare to completely standardized betas listed in 
Table 15). 
Figure 6 
Final R TPCO Path Models With Parameter Estimates 
Coping 
Enhancement 
Topic 
Groups 
Topic 
Groups 
1.0 
1.0 
.771 
.201 .960 
.782 
.229 .948 
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Note. Circles indicate latent variables, boxes are observed indicators, anchored arrows 
represent causal pathways, and unanchored arrows represent error variance. Measurement 
parameters are omitted for ease of presentation. All parameters are completely 
standardized estimates, significant at p < . 10. 
CHAPTER6 
DISCUSSION 
The measurement hypotheses of this study were well supported by confirmatory 
factor analyses. The M4 factor structure applied to IDDS and SCQ data yielded excellent 
fit when Coping and Enhancement were considered together, as well as when they were 
broken into separate models, confirming prior research using these instruments (Parrella, 
l 996a, l 996b ). The items comprising Participation, too, yielded a single well-fitting factor 
as predicted, and this result held for data based on the first week of treatment as well as 
for participation data from the entire length of stay. This set of confirmatory factor 
analyses provided a solid foundation for considering the structural hypotheses represented 
by the path analyses. 
Path hypotheses, however, received only limited support. Although the final RPCO 
trimmed path models produced good fit, none of the six paths represented in the Coping 
RPCO model were significant at either the . 05 or the . I 0 level when relapse status was 
used as the outcome measure. For the Enhancement RPCO with relapse status, which also 
demonstrated good fit, only the B path representing prediction of confidence at discharge 
from risk at baseline achieved significance. This lack of evidence of predictive power for 
both the Coping and Enhancement RPCO models in regard to relapse status was robust 
across the model variants involving length of stay that were considered: neither length of 
73 
stay in days nor participation calculated across length of stay appeared to provide 
incremental predictive power with respect to relapse status. 
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When relapse latency was used as the outcome measure, both the Coping and 
Enhancement RPCO models converged with findings from previous research on smoking 
cessation treatment. Abstinence self-efficacy at discharge, or confidence, was found to be 
the only significant predictor of relapse latency in both cases, accounting for about 4% of 
latency variance in the Coping model and about 5% of the variance in the latency measure 
in the Enhancement model. In both cases, greater confidence meant longer time to first 
use. These results, too, were robust across length of stay model variants, and they held for 
the subgroup of individuals who reported use at follow-up as well as for the sample as a 
whole (results for those who used mirrored results for the sample as a whole, and so were 
not presented here). The power of LR step tests to detect effects in the RPCO models 
described in this study was low for the non-significant paths, but the magnitude of the 
coefficients for these paths - as represented by estimated parameters in the unconstrained 
solutions - suggested that such effects would have accounted for only about I% of the 
variance in the respective criterion variables, and so would not have been particularly 
meaningful even if they had attained statistical significance. 
Nevertheless, failure to find significant effects of participation in the RPCO models 
raises questions about the conceptualization of participation used in this study. Although 
motivation and participation are not the same thing, they are clearly related, so an inability 
to demonstrate participation effects reinforces Miller's (1985) contention that it can be 
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difficult to operationalize patient motivation adequately. One possibility is that TPS 
volunteers who were involved enough in the study to provide data at all four points of 
data collection (i.e., at baseline, during treatment, at discharge, and at the six-month 
follow-up) represent a subset of compliant individuals, producing a restriction of range for 
participation that lowered correlations with other measures. The participation items, 
however, were normally distributed, lacking either skewness or excessive kurtosis, and 
this argues against restriction of range due to volunteer status. Another possibility is that 
the stochastic exposure assumption was faulty- i.e., the assumption that more 
participation implies more exposure to the sources of self-efficacy information (i.e., 
visceral experience, vicarious information, verbal persuasion, and performance) identified 
by Bandura (1977). Correlations of performance items with other workbook measures, 
however, argue against this interpretation as well. Participation was inversely related to 
self-reported craving and negative mood in the TPS, and it was positively correlated with 
the perceived helpfulness of other patients, perceived program impact, and perceived 
results at discharge. Other correlational analyses demonstrated significant associations 
between participation and both patient and therapist ratings of patient motivation at 
baseline (cf, Parrella et al., 1993). Furthermore, a previous investigation using this index 
showed that both general self-efficacy and positive outcome expectations of treatment at 
baseline predicted a significant proportion of participation variance (Parrella, 1995). 
Of course failure to reject the null hypothesis that participation didn't have 
significant effects in RPCO models doesn't prove this to be the case. Yet the general 
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nature of the participation measure used here doesn't take into account potentially 
significant confounds. Patients may not have felt that program materials made sense or 
applied to them, or they may have participated from the perspective of critic, selectively 
seeking attitudinally-congruent information. Nor does the notion of perceived participation 
control for variation that may be attributable to differential anchors for the referents 
embodied in the items - for instance, objectively similar levels of effort or contribution 
may have been perceived and rated differently depending on factors such as extroversion 
or social anxiety. In other words, the meaning of participation may have varied depending 
on a number of circumstances. It is not clear, for example, that making several comments 
on other people's problems during many group sessions necessarily implies more exposure 
to self-efficacy information than would a single difficult admission over the course of an 
entire treatment episode. If the question comes down to "Who needs what?" a global 
index of overall participation may not be specific enough to address the idea that some 
patients need sensitization or motivation to change while others who are already motivated 
need training in skills like controlling anger or managing anxiety. A more compelling test 
of study hypotheses, then, would probably require less global and less subjective measures 
of exposure to a wider variety of potentially important treatment components. 
Having said that, supplementary analyses in which a dose measure of topic groups 
was introduced produced additional findings that also may help to explain these results. 
Both the Coping and Enhancement R TPCO models showed statistically significant paths 
from topic group dose to discharge self-efficacy. The coefficients for these paths were 
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negative, indicating that more exposure to topic groups tended to produce lower 
abstinence self-efficacy. Although this result may at first seem counter-intuitive, MMCD 
treatment is based on a disease model of alcoholism, and the disease model - with its 
focus on loss-of-control drinking and the unalterable nature of alcoholism - stresses the 
fragile nature of recovery, as exemplified by slogans such as "one day at a time." This 
philosophical framework implies that abstinence self-efficacy, or confidence, is anathema 
to the ongoing process of maintaining abstinence, and a treatment approach emphasizing 
that viewpoint is consistent with the topic group results found here. 
Inclusion of the topic groups measure also led to a borderline level of statistical 
significance for the path predicting self-efficacy from participation in the Enhancement 
model, a predicted effect that was opposite in direction to the effect of topic groups. 
These findings suggest that MMCD treatment may produce competing effects on self-
efficacy at discharge, providing support for the contentions of Marlatt (1985) and Rollnick 
and Heather (1982) that the disease model loss-of-control tenet embodied in MMCD 
treatment may in fact serve to reduce the likelihood of subsequent abstinence. Simply 
adding the opposing indirect effects on latency of topic groups and perceived participation 
in the Enhancement model demonstrates how the net decrease in latency serves to obscure 
the somewhat smaller but nonetheless positive contribution of patient participation. 
These results support the idea that abstinence self-efficacy predicts relapse latency, 
as Bandura's (1977, 1986) self-efficacy theory would suggest. The absence of direct paths 
to latency from topic groups and participation also indicates that the competing effects on 
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latency attributable to these two variables in the Enhancement R TPCO were completely 
mediated by self-efficacy at discharge. That finding further reinforces the intent behind this 
study, to assess MMCD treatment using self-efficacy as a common metric to examine 
treatment effects. Moreover, although a lack of overall effects for MMCD treatment 
programs has often been attributed to the "washing out" of differential treatment 
effectiveness for different patients that results from considering only the main effects of 
treatment, the R TPCO findings reported here point to a somewhat different aspect of this 
issue: the possibility that a lack of overall effects may be due in part to opposing effects of 
different components or facets of the treatment experience. This interpretation 
underscores the value of process analysis, and it emphasizes the importance of attempts to 
isolate the "active ingredients" ofMMCD treatment for detailed study. 
Limitations. Several limitations of this study should be acknowledged. Because this 
was a naturalistic observational study based on correlational analysis of self-report data, 
rather than a controlled experiment in which variables were manipulated and observed 
more objectively, it would be inappropriate to draw unequivocal conclusions on the basis 
of the results reported here. The longitudinal nature of data collection obviates some of 
the more egregious concerns plaguing causal interpretations of cross-sectional data, 
making it implausible, for example, that latency caused abstinence self-efficacy, or that 
participation caused risk. The results reported here do not, however, speak to issues like 
reciprocal causation, the validity of self-reports, or third-variable interpretations. It may 
well be, for instance, that risk and participation are reciprocally related across multiple 
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panels, or that some common unmeasured factor such as social desirability influenced 
reports of both abstinence self-efficacy and relapse latency. This research was not 
designed to address such questions, although the sensitivity analysis conducted for relapse 
latency suggests that inclusion of additional indicators that increase the reliability of the 
latency measurement would accentuate the effects described here. Additional studies in 
which potential confounds like these are specified and explored would be required to rule 
out such threats to validity. 
With regard to measurement issues, although most of the indicators used here 
showed excellent distributional properties, the SCQ scales evidenced some degree of both 
kurtosis and restriction of range. While models involving these indicators fit the data well 
and converged with results from other samples, kurtosis may have affected results in some 
way not immediately apparent. The degree of model fit, and the fact that the effect of 
abstinence self-efficacy on relapse latency was the only one to reach significance in RPCO 
models, suggest that this was not a serious problem. It should be noted, however, that the 
restricted range of SCQ scales probably attenuated correlations, biasing results in a 
conservative direction. This, along with latency unreliability, less-than-perfect self-report 
reliability, and the importance of post-discharge factors noted by other investigators (cf, 
Moos et al., 1990), undoubtedly contributed to the inability of self-efficacy to account for 
more than a small percentage of the variance in relapse latency. 
The use of abstinence status, a dichotomous categorical indicator, as an outcome 
measure, however, directly violates the normality assumptions of covariance structure 
analysis. Maximum likelihood estimation is in general considered relatively robust to 
violations of these assumptions, and the use of dichotomous indicators in covariance 
structure models is not unprecedented, being analogous to dummy coding in standard 
regression analyses (see, for example, Hayduk, 1987, who illustrates this with several 
models incorporating categorical indicators). Bollen (1989) cites robustness studies 
suggesting that it is excessive kurtosis, rather than the number of categories, that may 
create problems in covariance structure models with categorical variables, producing 
inflated chi-square values and standard errors. Examination of the solutions involving 
relapse status in this sample shows chi-square values and standard errors comparable in 
magnitude to those obtained from the continuous latency measure. Nevertheless, the 
relapse status results reported here should be interpreted cautiously, especially given the 
absence of significant effects for the predictive paths tested in status-based models. 
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Another important issue involves sample size and the criteria used to assess 
statistical significance. In this study, a relatively small number of subjects provided data 
from all four instruments, resulting in low power to detect small effect sizes. This situation 
was complicated by the opposing implications of the alpha cutoff for the LR statistic and 
the chi-square test of overall model fit, which can make choosing a single level of 
significance problematic. If alpha is lowered to prevent capitalization on chance in the LR 
tests, models that provide less fit will be accepted using this alpha value as a decision 
criterion for the chi-square test. If alpha is raised to make the chi-square test more 
stringent, this relaxes the criterion for LR tests. Furthermore, as noted by Bollen (1989), 
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when repeated tests are performed on the same data, as when comparing different models, 
the resulting chi-square test statistics are correlated, and the usual probability levels do not 
reflect this lack of independence. For these reasons, all results were considered at 
traditionally-accepted alpha levels of both .05 and .10, and adjunctive fit indices were 
used, but no correction for the number of tests conducted in this study was performed. 
Consequently, cross-validation of the findings reported here assumes added importance. 
Future directions. A number of directions for future research are indicated. Given 
the possibility of competing effects for different elements ofMMCD treatment, it is 
important to try to operationalize these elements using more objective measures. For 
example, structured inventories with behavior-based response options might help to 
address the subjective nature of the participation index, whereas a voucher system might 
enable tracking of service component delivery. Multiple sources of participation data (e.g., 
including participation ratings from therapists as well as patients) could be used to address 
this issue. A series of measures specifically designed to tap Bandura' s ( 1977) four sources 
of self-efficacy information seems the next logical step. 
Given that a significant contribution of pre-existing outcome expectations to 
subsequent treatment participation has been demonstrated (cf, Parrella, 1995), outcome 
expectations and other patient characteristics such as psychiatric comorbidity would be 
important additions in further tests of the model. The results of this study should be cross-
validated on other samples, with larger numbers of subjects, and it would be interesting to 
see if findings vary by substance type, as previous work (e.g., Filstead, Parrella, & Ebbitt, 
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1988; Ross, Filstead, Parrella, & Rossi, 1994) has shown both commonalities and 
differences in the hierarchy of risk situations across substances of primary abuse. Therapist 
characteristics, too, have been associated with the differential treatment success of clients 
(e.g., McLellan, Woody, Luborsky, & Goehl, 1988), and since different facilities introduce 
both unique as well as programmatic variance, a multi-site replication in which both 
program and therapist characteristics are incorporated would allow specific tests of these 
factors. 
Summary. Although the small sample size raised some questions about the power 
of statistical tests to detect small effect sizes, the present investigation demonstrated that 
abstinence self-efficacy at discharge from MMCD treatment predicted subsequent relapse 
latency, converging with similar findings from research on smoking cessation treatment. 
Process analyses based on covariance structure modeling revealed significant influences on 
self-efficacy for both a general measure of treatment participation and for a more specific 
dose-related measure of treatment exposure, suggesting that different aspects of the 
treatment program may have exerted competing effects on self-efficacy and, consequently, 
produced opposing indirect effects on relapse latency. These results support the use of 
self-efficacy as a common metric for examining addiction treatment based on disease 
model principles, and they emphasize the importance of process analysis as a mechanism 
for identifying and assessing the "active ingredients" of MMCD programs. 
APPENDIX 
Following is the PREUS code used to generate the covariance matrices used in 
the RPCO models, along with output comprising the resulting covariance matrices and 
univariate and multivariate descriptive statistics for the observed indicators. Also included 
are the USREL commands used to specify the three RPCO models in Tables 9 and 13 
(i.e., the uncorrelated baseline, fully constrained, and final trimmed models). PREUS and 
USREL commands are listed separately for the Coping and Enhancement RPCO models. 
Note that the order of variables here differs from the order of presentation of the zero-
order correlations in Table 3. 
Coping 
subtitle 'RPCO, generate Coping covariance matrix'. 
prelis 
/variables= RNES RIPC RNPS PEFFOR T PMOTIVN PCONTRB 
CNES CIPC CNPS TTFUPCT (CO) 
/missing=listwise exclude /type=covariance 
/print=kurtosis /matrix=out (*). 
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TOTAL SAMPLE SIZE = 109 
UNIVARIATE SUMMARY STATISTICS FOR CONTINUOUS VARIABLES 
VARIABLE MEAN ST. DEV. SKEWNESS KURTOSIS MINIMUM 
RNES S0.890 27.810 -.lSO -.967 .000 
RIPC 39.661 27.lSO .349 -.714 .000 
RNPS 36.477 2S.943 .432 -.707 .000 
PEFFORT 4.461 .767 -.S20 -.006 2.300 
PMOTIVN 4.641 .7SS -.281 -.484 2.700 
PCONTRB 4.4S3 .847 -.407 -.307 2.200 
CNES 77.804 18.991 -. 713 -.442 30.000 
CIPC 81.449 18. 321 -1.121 1.124 11.000 
CNPS 83.613 18. 399 -1.172 .782 18.000 
TT FU PCT 76.987 36.413 -1.2S3 -.100 .000 
RELATIVE MULTIVARIATE KURTOSIS = .113 7140+01 
COVARIANCE MATRIX 
RNES RIPC RNPS PEFFORT 
RNES 773. 39S 
RIPC 67S.842 737.llS 
RNPS S74.294 S30.423 673.030 
PEFFORT .277 -.044 .374 .S88 
PMOTIVN -2.836 -3.026 -1. 746 .423 
PCONTRB -.474 -.988 .830 .sos 
CNES -82.489 -77.064 -94.S76 .770 
CIPC -73.820 -90.046 -10S.1S6 .473 
CNPS -27.251 -30.694 -112.196 .770 
TT FU PCT -89. 392 -27. S77 -S.464 2.426 
COVARIANCE MATRIX 
CNES CIPC CNPS TT FU PCT 
CNES 360.6S4 
CIPC 316.989 33S.664 
CNPS 287.968 288.900 338. S28 
TT FU PCT 113.4Sl 133 .036 117.744 132S.932 
subtitle 'RPCO, Coping only, uncorrelated baseline'. 
lisrel 
l"RPCO, Coping only, uncorrelated baseline" 
Ida ni=IO 
Imo nx= I 0 nk= I 0 lx=id td=ze ph=di 
lou sc. 
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FREQ. MAXIMUM FREQ. 
6 100.000 2 
10 100.000 3 
7 100.000 1 
1 6.000 1 
1 6.000 2 
1 6.000 2 
1 100.000 11 
1 100.000 21 
1 100.000 30 
7 100.000 70 
PMOTIVN PCONTRB 
.S69 
.4S7 .717 
.214 .798 
.093 .611 
-.184 .429 
3.1S3 2.73S 
subtitle 'RPCO, Coping only, constrained'. 
lisrel 
/"RPCO, Coping only, constrained" 
/da ni=IO 
Imo ny= I 0 ne=4 te=sy,fi be=sd ps=fi 
/fi ly I I ly 4 2 ly 7 3 ly 10 4 
/va I ly I I ly 4 2 ly 7 3 ly I 0 4 
/fr ly 2 I ly 3 I ly 5 2 ly 6 2 ly 8 3 ly 9 3 
/fr te I I te 2 2 te 3 3 te 4 4 te 5 5 te 6 6 te 7 7 te 8 8 te 9 9 
/fr te I 7 te 2 8 te 3 9 
/fr ps I I ps 2 2 ps 3 3 ps 4 4 
/fi be 2 I be 3 I be 3 2 be 4 I be 4 2 be 4 3 
/va 0 be 2 I be 3 I be 3 2 be 4 I be 4 2 be 4 3 
/le 
/coprisk partic copconf latency 
Jou ad=off it=500 sc se tv. 
subtitle 'RPCO, Coping only, trimmed'. 
lisrel 
/"RPCO, Coping only, trimmed" 
/da ni=IO 
Imo ny= I 0 ne=4 te=sy,fi be=sd ps=fi 
/fi ly I I ly 4 2 ly 7 3 ly I 0 4 
/va I ly I I ly 4 2 ly 7 3 ly I 0 4 
/fr ly 2 I ly 3 I ly 5 2 ly 6 2 ly 8 3 ly 9 3 
/fr te I I te 2 2 te 3 3 te 4 4 te 5 5 te 6 6 te 7 7 te 8 8 te 9 9 
/fr te I 7 te 2 8 te 3 9 
/fr ps I I ps 2 2 ps 3 3 ps 4 4 
/fi be 2 I be 3 I be 3 2 be 4 I be 4 2 
/va 0 be 2 I be 3 I be 3 2 be 4 I be 4 2 
/le 
/coprisk partic copconf latency 
Jou ad=off it=500 sc se tv. 
85 
Enhancement 
subtitle 'RPCO, generate Enhancement covariance matrix'. 
prelis 
/variables= RPSS RSP RPES PEFFORT PMOTIVN PCONTRB 
CPSS CSP CPES TTFUPCT (CO) 
/missing=listwise exclude /type=covariance 
/print=kurtosis /matrix=out (*). 
TOTAL SAMPLE SIZE = 109 
UNIVARIATE SUMMARY STATISTICS FOR CONTINUOUS VARIABLES 
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VARIABLE MEAN ST. DEV. SKEWNESS KURTOSIS MINIMUM FREQ. MAXIMUM FREQ. 
RPSS 
RSP 
RPES 
PEFFORT 
PMOTIVN 
PCONTRB 
CPSS 
CSP 
CPES 
TT FU PCT 
51. 266 
50.092 
49.587 
4.461 
4.641 
4.453 
82.667 
79.170 
84.618 
76.987 
30.551 
30.539 
27.798 
.767 
.755 
.847 
19.225 
22.666 
18.975 
36.413 
-.267 
-.204 
-.221 
-.520 
-.281 
-.407 
-1. 066 
-1. 062 
-1.158 
-1.253 
-1.143 
-1.077 
-.846 
-.006 
-.484 
-.307 
.110 
.427 
.381 
-.100 
.000 
.000 
.000 
2.300 
2.700 
2.200 
32.000 
6.000 
25 .000 
.000 
RELATIVE MULTIVARIATE KURTOSIS = .1110250+01 
RPSS 
RSP 
RPES 
PEFFORT 
PMOTIVN 
PCONTRB 
CPSS 
CSP 
CPES 
TT FU PCT 
CPSS 
CSP 
CPES 
TT FU PCT 
COVARIANCE MATRIX 
RPSS 
933. 382 
854.290 
624.231 
2.502 
- . 535 
1.624 
-104.465 
-148.701 
-51.086 
-64.561 
RSP 
932.621 
590.038 
2.734 
-1. 016 
2.248 
-101.148 
-186.586 
-46.014 
-94.462 
COVARIANCE MATRIX 
CPSS 
369.614 
364.167 
313.591 
161.189 
CSP 
513.764 
304.989 
116.527 
RPES 
772.745 
-2.354 
-4.540 
-2.874 
-93.076 
-100.500 
-72.844 
-73.725 
CPES 
360.063 
PEFFORT 
.588 
.423 
.505 
1.054 
.305 
2.519 
2.426 
TT FU PCT 
117.601 1325.932 
10 100.000 
11 100.000 
11 100.000 
1 6.000 
1 6.000 
1 6.000 
1 100.000 
1 100.000 
1 100.000 
7 100.000 
PMOTIVN 
.569 
.457 
1. 359 
.841 
1. 347 
3.153 
PCONTRB 
.717 
1.718 
1.853 
3.093 
2.735 
2 
3 
4 
1 
2 
2 
28 
28 
45 
70 
subtitle 'RPCO, Enhancement only, uncorrelated baseline'. 
lisrel 
/"RPCO, Enhancement only, uncorrelated baseline" 
/da ni=IO 
Imo nx= I 0 nk= I 0 lx=id td=ze ph=di 
/ou sc. 
subtitle 'RPCO, Enhancement only, constrained'. 
lisrel 
/"RPCO, Enhancement only, constrained" 
/da ni=IO 
Imo ny= I 0 ne=4 te=sy,fi be=sd ps=fi 
/fi ly I I ly 4 2 ly 7 3 ly I 0 4 
/va I ly I I ly 4 2 ly 7 3 ly I 0 4 
/fr ly 2 I ly 3 I ly 5 2 ly 6 2 ly 8 3 ly 9 3 
/fr te 2 2 te 3 3 te 4 4 te 5 5 te 6 6 te 8 8 te 9 9 
/fr te 2 3 te 8 9 te I 7 te 2 8 te 3 9 
/fr ps I I ps 2 2 ps 3 3 ps 4 4 
/fi be 2 I be 3 I be 3 2 be 4 I be 4 2 be 4 3 
/va 0 be 2 I be 3 I be 3 2 be 4 I be 4 2 be 4 3 
/le 
/enhrisk partic enhconflatency 
/ou ad=off it=SOO sc se tv. 
subtitle 'RPCO, Enhancement only, trimmed'. 
lisrel 
/"RPCO, Enhancement only, trimmed" 
/da ni=IO 
Imo ny=IO ne=4 te=sy,fi be=sd ps=fi 
/fi ly I I ly 4 2 ly 7 3 ly 10 4 
/va I ly I I ly 4 2 ly 7 3 ly I 0 4 
/fr ly 2 I ly 3 I ly 5 2 ly 6 2 ly 8 3 ly 9 3 
/fr te 2 2 te 3 3 te 4 4 te 5 5 te 6 6 te 8 8 te 9 9 
/fr te 2 3 te 8 9 te I 7 te 2 8 te 3 9 
/fr ps I I ps 2 2 ps 3 3 ps 4 4 
/fi be 2 I be 3 2 be 4 I be 4 2 
/va 0 be 2 I be 3 2 be 4 I be 4 2 
/le 
/enhrisk partic enhconf latency 
/ou ad=off it=SOO sc se tv. 
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